BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423-39. [PMID: 20564651 DOI: 10.1002/ibd.21349] [Cited by in Crossref: 640] [Cited by in F6Publishing: 532] [Article Influence: 53.3] [Reference Citation Analysis]
Number Citing Articles
1 Pang X, Song H, Li X, Xu F, Lei B, Wang F, Xu J, Qi L, Wang L, Tan G. Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis. J Transl Med 2023;21:30. [PMID: 36647141 DOI: 10.1186/s12967-023-03881-6] [Reference Citation Analysis]
2 Cenni S, Casertano M, Trani M, Pacella D, Martinelli M, Staiano A, Miele E, Strisciuglio C. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. Eur J Pediatr 2023. [PMID: 36637538 DOI: 10.1007/s00431-022-04771-7] [Reference Citation Analysis]
3 Miura N, Okuda S. Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics. Computational and Structural Biotechnology Journal 2023. [DOI: 10.1016/j.csbj.2023.01.015] [Reference Citation Analysis]
4 Alahmari AA, AlShawaf SH, Meshikhes HA, Aleid BA, Aldossari RM, Shafey MM, Aladsani AA, Al-Ibraheem AA, AlRubia NM, AlQahtani SA. Quality of Life Among Children with Inflammatory Bowel Disease in Saudi Arabia: A Cross-Sectional Study. Int J Gen Med 2022;15:8775-86. [PMID: 36601651 DOI: 10.2147/IJGM.S394914] [Reference Citation Analysis]
5 Leiz M, Knorr M, Moon K, Tischler L, de Laffolie J, van den Berg N. Diagnostic delay in children with inflammatory bowel disease in the German-Austrian patient registry CEDATA-GPGE 2014-2018. Sci Rep 2022;12:21162. [PMID: 36477258 DOI: 10.1038/s41598-022-25487-6] [Reference Citation Analysis]
6 Wu Y, Huang L, Sun J, Wang H, Fang L, Miao J. Prevalence and predictors of medication non-adherence in children with inflammatory bowel disease in China: A cross-sectional study. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1062728] [Reference Citation Analysis]
7 Gallo-bernal S, Cahalane AM, Gee MS. Percutaneous Image-Guided Drainage of Abdominal Fluid Collections in Children: Technical Considerations and Clinical Scenarios. Digestive Disease Interventions 2022. [DOI: 10.1055/s-0042-1759547] [Reference Citation Analysis]
8 Cerdó T, García-santos JA, Rodríguez-pöhnlein A, García-ricobaraza M, Nieto-ruíz A, G. Bermúdez M, Campoy C. Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders. Nutrients 2022;14:4691. [DOI: 10.3390/nu14214691] [Reference Citation Analysis]
9 Frans Maruma, Harriet Makuru. Paediatric Pyodermatitis-Pyostomatitis Vegetans Without Underlying Inflammatory Bowel Disease: A Case Report of a 3-Year-Old African Girl. Clin Cosmet Investig Dermatol 2022;15. [PMID: 36353092 DOI: 10.2147/CCID.S383926] [Reference Citation Analysis]
10 Xu L, Huang G, Cong Y, Yu Y, Li Y. Sex-related Differences in Inflammatory Bowel Diseases: The Potential Role of Sex Hormones. Inflamm Bowel Dis 2022;28:1766-75. [PMID: 35486387 DOI: 10.1093/ibd/izac094] [Reference Citation Analysis]
11 Allen SJ, Belnour S, Renji E, Carter B, Bray L, Allen A, Jones E, Urban B, Moule S, Wang D, Playford RJ. Dietary Therapy to Improve Nutrition and Gut Health in Paediatric Crohn’s Disease; A Feasibility Study. Nutrients 2022;14:4598. [DOI: 10.3390/nu14214598] [Reference Citation Analysis]
12 Ferreiro-iglesias R, Piqueras M, Ricart E, Sempere L, Roca M, Martín de Carpi J, Bentitez O, Zabana Y, Mañosa M, Rodríguez-moranta F, Barreiro-de Acosta M. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel Disease patients. Gastroenterología y Hepatología (English Edition) 2022. [DOI: 10.1016/j.gastre.2022.03.004] [Reference Citation Analysis]
13 Breugelmans T, Arras W, Boen LE, Borms E, Kamperdijk L, de Man J, van de Vijver E, van Gils A, de Winter BY, Moes N, Smet A. Aberrant Mucin Expression Profiles Associate With Pediatric Inflammatory Bowel Disease Presentation and Activity. Inflamm Bowel Dis 2022:izac217. [PMID: 36239641 DOI: 10.1093/ibd/izac217] [Reference Citation Analysis]
14 S Akkelle B, Ertem D, Volkan B, Tutar E. Phenotypic Pattern of Early Versus Later-Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country. J Pediatr Gastroenterol Nutr 2022;75:e61-6. [PMID: 35809240 DOI: 10.1097/MPG.0000000000003557] [Reference Citation Analysis]
15 Leiz M, Knorr M, Moon K, Tischler L, Sohrabi K, Cantez S, Däbritz J, de Laffolie J, Berg NVD. Can patient registries contribute to guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease.. [DOI: 10.21203/rs.3.rs-1901469/v1] [Reference Citation Analysis]
16 Croft NM, de Ridder L, Griffiths AM, Hyams JS, Ruemmele FM, Turner D, Cheng K, Lutsar I, Greco M, Gołębiewska Z, Laumond F, Cavaller-Bellaubi M, Elgreey A, Altepeter TA, Pallidis C, Norga K, Nelson R, Crandall W, Vassal G. Paediatric inflammatory bowel disease: a multi-stakeholder perspective to improve development of drugs for children and adolescents. J Crohns Colitis 2022:jjac135. [PMID: 36130314 DOI: 10.1093/ecco-jcc/jjac135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kern I, Schoffer O, Richter T, Kiess W, Flemming G, Winkler U, Quietzsch J, Wenzel O, Zurek M, Manuwald U, Hegewald J, Li S, Weidner J, de Laffolie J, Zimmer K, Kugler J, Laass MW, Rothe U. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trends. PLoS ONE 2022;17:e0274117. [DOI: 10.1371/journal.pone.0274117] [Reference Citation Analysis]
18 Choe YJ, Han K, Shim JO. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study. Aliment Pharmacol Ther 2022;56:980-8. [PMID: 35791668 DOI: 10.1111/apt.17125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Arnone D, Chabot C, Heba AC, Kökten T, Caron B, Hansmannel F, Dreumont N, Ananthakrishnan AN, Quilliot D, Peyrin-Biroulet L. Sugars and Gastrointestinal Health. Clin Gastroenterol Hepatol 2022;20:1912-1924.e7. [PMID: 34902573 DOI: 10.1016/j.cgh.2021.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Höyhtyä M, Korpela K, Saqib S, Junkkari S, Nissilä E, Nikkonen A, Dikareva E, Salonen A, de Vos WM, Kolho KL. Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2023;29:116-24. [PMID: 36040412 DOI: 10.1093/ibd/izac182] [Reference Citation Analysis]
21 Hellmann J, Ta A, Ollberding NJ, Bezold R, Lake K, Jackson K, Dirksing K, Bonkowski E, Haslam DB, Denson LA. Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac175. [PMID: 35972440 DOI: 10.1093/ibd/izac175] [Reference Citation Analysis]
22 Bodini G, Levo F, Facchini C, Buccilli S, Arrigo S, Giannini EG. Letter to the Editor. J Paediatr Child Health 2022. [PMID: 35969117 DOI: 10.1111/jpc.16154] [Reference Citation Analysis]
23 Alhadab AA, AlMahamed SN, Hassan IE, Hammo AH. The impact of inflammatory bowel diseases on the quality of life of Saudi pediatric patients: A cross-sectional study. Saudi J Gastroenterol 2022;28:448-55. [PMID: 35946259 DOI: 10.4103/sjg.sjg_162_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Halfvarson J, Ludvigsson JF, Bresso F, Askling J, Sachs MC, Olén O. Age determines the risk of familial inflammatory bowel disease-A nationwide study. Aliment Pharmacol Ther 2022;56:491-500. [PMID: 35460098 DOI: 10.1111/apt.16938] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mahalingam N, Tkach JA, Denson LA, Dillman JR. Bowel wall MRI T1 relaxation estimates for assessment of intestinal inflammation in pediatric Crohn's disease. Abdom Radiol (NY) 2022;47:2730-8. [PMID: 35657390 DOI: 10.1007/s00261-022-03560-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 El Koofy NM, Moawad EMI, Yassin NA, Almohammady MN, Ibrahim GS, El Mougy FA, El Ayadi AA, Tarek S. Basic anthropometry, micronutrients status and growth velocity of patients with early-onset inflammatory bowel disease: A prospective cohort study. Arab J Gastroenterol 2022:S1687-1979(22)00056-9. [PMID: 35918289 DOI: 10.1016/j.ajg.2022.06.004] [Reference Citation Analysis]
27 Schwartz NR, Mcnichol SR, Devine B, Phipps AI, Roth JA, Suskind DL. Assessing Barriers to use of the Specific Carbohydrate Diet in Pediatric Inflammatory Bowel Disease: A Qualitative Study. JPGN Reports 2022;3:e239. [DOI: 10.1097/pg9.0000000000000239] [Reference Citation Analysis]
28 Martins AL, Fróes RSB, Zago-Gomes MP. Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil. World J Clin Pediatr 2022; 11(4): 341-350 [DOI: 10.5409/wjcp.v11.i4.341] [Reference Citation Analysis]
29 Duclaux-loras R, Ley D. Les nouvelles thérapies nutritionnelles dans la maladie de Crohn de l’enfant. Perfectionnement en Pédiatrie 2022;5:88-91. [DOI: 10.1016/j.perped.2022.04.007] [Reference Citation Analysis]
30 Kang C, Yoon H, Park S, Kim J, Han K, Kim S, Koh H, Lee MJ, Shin HJ. Initial Abdominal CT and Laboratory Findings Prior to Diagnosis of Crohn's Disease in Children. Yonsei Med J 2022;63:675-82. [PMID: 35748079 DOI: 10.3349/ymj.2022.63.7.675] [Reference Citation Analysis]
31 Davidson N, Rutsky J, Bricker JB, Smith J, Maltz RM, Dotson JL, Michel HK, Boyle B. 6- and 12-Month Outcomes after 90:10 Enteral Nutrition Induction Therapy in Pediatric Crohn's Disease. J Pediatr Gastroenterol Nutr 2022;75:70-5. [PMID: 35621916 DOI: 10.1097/MPG.0000000000003475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Schmid F, Chao C, Däbritz J. Pathophysiological Concepts and Management of Pulmonary Manifestation of Pediatric Inflammatory Bowel Disease. IJMS 2022;23:7287. [DOI: 10.3390/ijms23137287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Gordon IO, Abushamma S, Kurowski JA, Holubar SD, Kou L, Lyu R, Rieder F. Paediatric Ulcerative Colitis Is a Fibrotic Disease and Is Linked with Chronicity of Inflammation. J Crohns Colitis 2022;16:804-21. [PMID: 34849664 DOI: 10.1093/ecco-jcc/jjab216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Hercun J, Willems P, Bilodeau M, Vincent C, Alvarez F. Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis. JPGN Reports 2022;3:e220. [DOI: 10.1097/pg9.0000000000000220] [Reference Citation Analysis]
35 Lund K, Larsen MD, Knudsen T, Kjeldsen J, Nielsen RG, Brage S, Nørgård BM. Physical activity measured by accelerometry in paediatric and young adult patients with inflammatory bowel disease. BMC Gastroenterol 2022;22:290. [PMID: 35672666 DOI: 10.1186/s12876-022-02358-y] [Reference Citation Analysis]
36 Menze L, Wenzl TG, Pappa A. [KARLOTTA (Kids + Adolescents Research Learning On Tablet Teaching Aachen) - randomized controlled pilot study for the implementation of a digital educational app with game of skill for pediatric patients with inflammatory bowel disease]. Z Gastroenterol 2022. [PMID: 35672003 DOI: 10.1055/a-1799-9267] [Reference Citation Analysis]
37 Grandmougin A, D'Amico F, Remen T, Danese S, Bonneton M, Galloy MA, Peyrin-Biroulet L, Laurent V. Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease. Dig Dis Sci 2022;67:2462-70. [PMID: 34159487 DOI: 10.1007/s10620-021-07016-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Gana JC, Sepúlveda A, Orlanski-meyer E, Villarroel del Pino LA, de la Piedra Bustamante MJ, Olivares Labbe MT; Cochrane Gut Group. Tumour necrosis factor-alpha antagonists for treatment of paediatric Crohn’s disease. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014497] [Reference Citation Analysis]
39 Klomberg RCW, Vlug LE, de Koning BAE, de Ridder L. Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure. Front Pediatr 2022;10:885876. [PMID: 35601436 DOI: 10.3389/fped.2022.885876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Arcucci MS, Contreras MB, Gallo J, Antoniska MA, Busoni V, Tennina C, D'Agostino D, Kakisu MH, Weyersberg C, Orsi M. Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years. Pediatr Gastroenterol Hepatol Nutr 2022;25:218-27. [PMID: 35611373 DOI: 10.5223/pghn.2022.25.3.218] [Reference Citation Analysis]
41 Lv H, Zhang L, Han Y, Wu L, Wang B. The Development of Early Life Microbiota in Human Health and Disease. Engineering 2022;12:101-14. [DOI: 10.1016/j.eng.2020.12.014] [Reference Citation Analysis]
42 Virkkula A, Kivela L, Hiltunen P, Sotka A, Huhtala H, Kurppa K, Repo M. Prevalence and Clinical Significance of Helicobacter Pylori-negative Chronic Gastritis in Children. J Pediatr Gastroenterol Nutr 2022;74:949-55. [PMID: 35258500 DOI: 10.1097/MPG.0000000000003440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Levine AE, Zheng HB, Suskind DL. Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations. Pediatr Drugs. [DOI: 10.1007/s40272-022-00503-4] [Reference Citation Analysis]
44 Ventin-Holmberg R, Höyhtyä M, Saqib S, Korpela K, Nikkonen A, Salonen A, de Vos WM, Kolho KL. The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α. Sci Rep 2022;12:6654. [PMID: 35459927 DOI: 10.1038/s41598-022-10548-7] [Reference Citation Analysis]
45 Kuenzig ME, Fung SG, Marderfeld L, Mak JWY, Kaplan GG, Ng SC, Wilson DC, Cameron F, Henderson P, Kotze PG, Bhatti J, Fang V, Gerber S, Guay E, Kotteduwa Jayawarden S, Kadota L, Maldonado D F, Osei JA, Sandarage R, Stanton A, Wan M, Benchimol EI; InsightScope Pediatric IBD Epidemiology Group. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology 2022;162:1147-1159.e4. [PMID: 34995526 DOI: 10.1053/j.gastro.2021.12.282] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 41.0] [Reference Citation Analysis]
46 Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry. Dig Liver Dis 2022;54:469-76. [PMID: 35125313 DOI: 10.1016/j.dld.2021.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Parente P, Mastracci L, Vanoli A, Fassan M, Pastore M, Bossa F, Francalanci P, Alaggio R, Graziano P, Grillo F. Pattern-based Histologic Approach in Very Early Onset IBD: Main Features and Differential Diagnosis. Adv Anat Pathol 2022;29:71-80. [PMID: 34620740 DOI: 10.1097/PAP.0000000000000323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
48 Yu Y, Zhao H, Luo Y, Lou J, Chen J, Fang Y. Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy. Dig Dis Sci 2022;67:997-1006. [PMID: 33818661 DOI: 10.1007/s10620-021-06917-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Sassine S, Savoie Robichaud M, Lin YF, Djani L, Cambron-Asselin C, Qaddouri M, Zekhnine S, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Changes in the clinical phenotype and behavior of pediatric luminal Crohn's disease at diagnosis in the last decade. Dig Liver Dis 2022;54:343-51. [PMID: 34756526 DOI: 10.1016/j.dld.2021.09.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 El-lababidi N. Inflammatory bowel disease in children - part 2: treatment and complications. Pediatr pro Praxi 2022;23:13-17. [DOI: 10.36290/ped.2022.002] [Reference Citation Analysis]
51 Mollah T, Lee D, Giles E. Impact of a new young adult inflammatory bowel disease transition clinic on patient satisfaction and clinical outcomes. J Paediatr Child Health 2022. [PMID: 35170119 DOI: 10.1111/jpc.15907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Balbale SN, Schäfer WLA, Davis T, Blake SC, Close S, Perry JE, Zarate RP, Ingram MC, Strople J, Johnson JK, Holl JL, Raval MV. Age- and Sex-Specific Needs for Children Undergoing Inflammatory Bowel Disease Surgery: A Qualitative Study. J Surg Res 2022;274:46-58. [PMID: 35121549 DOI: 10.1016/j.jss.2021.12.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Scarallo L, Bolasco G, Barp J, Bianconi M, di Paola M, Di Toma M, Naldini S, Paci M, Renzo S, Labriola F, De Masi S, Alvisi P, Lionetti P. Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission. Inflamm Bowel Dis 2022;28:183-91. [PMID: 33835155 DOI: 10.1093/ibd/izab046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
54 Shanbhag R. Is Early-onset Inflammatory Bowel Disease a Primary Immune Deficiency? Pediatric Infectious Disease 2022;3:125-127. [DOI: 10.5005/jp-journals-10081-1310] [Reference Citation Analysis]
55 Choe JY, Choi S, Song KH, Jang HJ, Choi KH, Yi DY, Hong SJ, Hwang JH, Cho SM, Kim YJ, Choe BH, Kang B. Incidence and Prevalence Trends of Pediatric Inflammatory Bowel Disease in the Daegu-Kyungpook Province From 2017 to 2020. Front Pediatr 2021;9:810173. [PMID: 35059365 DOI: 10.3389/fped.2021.810173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Saleem A, Zeeshan M, Hazoor F, Mustafa G. Sigmoidoscopic extent of ulcerative colitis and associated factors in Pakistani population. Pak J Med Sci 2022;38:276-80. [PMID: 35035439 DOI: 10.12669/pjms.38.1.4648] [Reference Citation Analysis]
57 Mansour HH, Alajerami YS, Abushab KM, Najim AA, Quffa KM. Diagnostic accuracy of CT enterography correlated to histopathology in the diagnosis of small bowel Crohn's disease. Ir J Med Sci 2022. [PMID: 35000116 DOI: 10.1007/s11845-021-02917-4] [Reference Citation Analysis]
58 Kumagai H, Shimizu T, Iwama I, Hagiwara SI, Kudo T, Takahashi M, Saito T, Kunisaki R, Uchino M, Hiraoka S, Naganuma M, Sugimoto K, Miyoshi J, Shibuya T, Hisamatsu T. A consensus statement on health-care transition for childhood-onset inflammatory bowel disease patients. Pediatr Int 2022;64:e15241. [PMID: 35895501 DOI: 10.1111/ped.15241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Rundle AL, Baron N, John RM. Care of the Child with a Gastrointestinal Disorder. Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach 2022. [DOI: 10.1007/978-3-030-90642-9_9] [Reference Citation Analysis]
60 Stănescu AMA, Simionescu AA, Grăjdeanu IV. Essential aspects of inflammatory bowel disease with childhood onset in primary medicine. Medic ro 2022;1:18. [DOI: 10.26416/med.145.1.2022.6210] [Reference Citation Analysis]
61 Tokita K, Shimizu H, Takeuchi I, Shimizu T, Arai K. Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan. Pediatr Gastroenterol Hepatol Nutr 2022;25:461. [DOI: 10.5223/pghn.2022.25.6.461] [Reference Citation Analysis]
62 Altepeter T, Wertheimer E, Lee JJ. Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward. Gastroenterology 2022;162:22-5. [PMID: 31229494 DOI: 10.1053/j.gastro.2019.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sassine S, Zekhnine S, Qaddouri M, Djani L, Cambron-Asselin C, Savoie-Robichaud M, Lin YF, Grzywacz K, Groleau V, Dirks M, Drouin É, Halac U, Marchand V, Girard C, Courbette O, Patey N, Dal Soglio D, Deslandres C, Jantchou P. Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open 2021;5:1373-81. [PMID: 34950781 DOI: 10.1002/jgh3.12684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Bardet A, Riccardi F, Torrents J, Capasso F, Devooght M, Buffat C, Fabre A, Piercecchi-marti M, Delteil C. Diagnostic d’une maladie inflammatoire rare et sévère de l’intestin chez un nourrisson présentant des ulcérations péri-orificielles. Annales de Pathologie 2021. [DOI: 10.1016/j.annpat.2021.11.007] [Reference Citation Analysis]
65 Graffigna G, Bosio C, Pagnini F, Volpato E, Previtali E, Leone S, D'Amico F, Armuzzi A, Danese S. Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement. BMC Psychol 2021;9:186. [PMID: 34839834 DOI: 10.1186/s40359-021-00692-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Barned C, Fabricius A, Stintzi A, Mack DR, O'Doherty KC. "The Rest of my Childhood was Lost": Canadian Children and Adolescents' Experiences Navigating Inflammatory Bowel Disease. Qual Health Res 2022;32:95-107. [PMID: 34818940 DOI: 10.1177/10497323211046577] [Reference Citation Analysis]
67 Schoepfer AM, Tran VDC, Rossel J, Sokollik C, Spalinger J, Safroneeva E, von Graffenried T, Godat S, Hahnloser D, Vavricka SR, Braegger C, Nydegger A; on behalf of the Swiss IBD Cohort Study Group. Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort. Inflamm Intest Dis. [DOI: 10.1159/000520995] [Reference Citation Analysis]
68 Lee WS, Song ZL, Wong SY, Gan CW, Koay ZL, Em JM, Chong SY, Lim CB, Wong SY, Chew KS, Kam CC. Environmental risk factors for inflammatory bowel disease: A case control study in Southeast Asian children. J Paediatr Child Health 2021. [PMID: 34761458 DOI: 10.1111/jpc.15830] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Mansour HH, Alajerami YS, Najim AA, Abushab KM. Computed Tomography Enterography Demonstrates Association to Histopathological Grading of Small Bowel Crohn’s Activity. ELECTRON J GEN MED 2021;18:em330. [DOI: 10.29333/ejgm/11317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Stulman MY, Asayag N, Focht G, Brufman I, Cahan A, Ledderman N, Matz E, Chowers Y, Eliakim R, Ben-Horin S, Odes S, Dotan I, Balicer RD, Benchimol EI, Turner D. Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study. Inflamm Bowel Dis 2021;27:1784-94. [PMID: 33438721 DOI: 10.1093/ibd/izaa341] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
71 Müller KE, Dezsőfi A, Cseh Á, Szűcs D, Vass N, Nemes É, Kadenczki O, Tárnok A, Szakos E, Guthy I, Kovács M, Karoliny A, Czelecz J, Tokodi I, Tomsits E, Veres G. Adherence to the Porto Criteria Based on the Hungarian Nationwide Pediatric Inflammatory Bowel Disease Registry (HUPIR). Front Pediatr 2021;9:710631. [PMID: 34631616 DOI: 10.3389/fped.2021.710631] [Reference Citation Analysis]
72 Sulkanen E, Repo M, Huhtala H, Hiltunen P, Kurppa K. Impact of diagnostic delay to the clinical presentation and associated factors in pediatric inflammatory bowel disease: a retrospective study. BMC Gastroenterol 2021;21:364. [PMID: 34620103 DOI: 10.1186/s12876-021-01938-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Meskina ER, Tselipanova EE, Sokhatyuk TA. Clinical case of a new coronavirus infection in a teenager with ulcerative colitis. Det infekc 2021;20:67-72. [DOI: 10.22627/2072-8107-2021-20-3-67-72] [Reference Citation Analysis]
74 Larrosa-haro A, Abundis-castro L, Contreras M, Gallo M, Peña-quintana L, Targa Ferreira C, Nacif P, Vázquez-frias R, Bravo S, Muñoz-urribarri A, Mejía-castro M, Orsi M, Amil-díaz J, Busoni V, Cohen-sabban J, Martin-capri F, Zablah R, Rodríguez-guerrero M, Sdepanian V. Tendencia epidemiológica de la enfermedad intestinal inflamatoria en pacientes pediátricos en América Latina: Grupo de Trabajo en Enfermedad Intestinal Inflamatoria, Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición Pediátrica (SLAGHNP). Revista de Gastroenterología de México 2021;86:328-334. [DOI: 10.1016/j.rgmx.2020.07.010] [Reference Citation Analysis]
75 Larrosa-Haro A, Abundis-Castro L, Contreras MB, Gallo MJ, Peña-Quintana L, Targa Ferreira CH, Nacif PA, Vázquez-Frías R, Bravo S, Muñoz-Urribarri AB, Mejía-Castro M, Orsi M, Amil-Díaz J, Busoni V, Cohen-Sabban J, Martin-Capri FJ, Zablah R, Rodríguez-Guerrero MG, Sdepanian VL. Epidemiologic trend of pediatric inflammatory bowel disease in Latin America: The Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) Working Group. Rev Gastroenterol Mex (Engl Ed) 2021;86:328-34. [PMID: 34518143 DOI: 10.1016/j.rgmxen.2021.07.004] [Reference Citation Analysis]
76 Madrazo-de la Garza J. Comentario editorial sobre tendencia epidemiológica de la enfermedad inflamatoria intestinal en pacientes pediátricos en América Latina: Grupo de Trabajo de Enfermedad Inflamatoria Intestinal de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición Pediátrica (SLAGHNP). Revista de Gastroenterología de México 2021;86:325-327. [DOI: 10.1016/j.rgmx.2021.04.001] [Reference Citation Analysis]
77 Madrazo-de la Garza JA. Editorial comment on the epidemiologic trend of pediatric inflammatory bowel disease in Latin America: The Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) Working Group. Rev Gastroenterol Mex (Engl Ed) 2021;86:325-7. [PMID: 34389289 DOI: 10.1016/j.rgmxen.2021.04.001] [Reference Citation Analysis]
78 Kim ES, Kim MJ. Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents. Clin Exp Pediatr 2022;65:21-8. [PMID: 34530520 DOI: 10.3345/cep.2021.00661] [Reference Citation Analysis]
79 Khan MR, Ulrich JA, Hull NC, Inoue A, Harmsen WS, Faubion WA Jr, Fletcher JG, Absah I. Perianal magnetic resonance imaging findings and their potential impact on outcome in children with perianal fistulizing Crohn disease. Pediatr Radiol 2021;51:2481-91. [PMID: 34490496 DOI: 10.1007/s00247-021-05158-w] [Reference Citation Analysis]
80 Ahola Kohut S, Forgeron P, Mcmurtry M, Weiser N, Iuliano A, Stinson J. Resilience Factors in Paediatric Inflammatory Bowel Disease: Health Care Provider, Parent and Youth Perspectives. J Child Fam Stud 2021;30:2250-2263. [DOI: 10.1007/s10826-021-02040-z] [Reference Citation Analysis]
81 Jain M, Venkataraman J. Inflammatory bowel disease: An Indian perspective. Indian J Med Res 2021;153:421-30. [PMID: 34380788 DOI: 10.4103/ijmr.IJMR_936_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 El Mouzan MI, Winter HS, Al Sarkhy AA, Korolev K, Menon R, Assiri AA. Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children. Saudi J Gastroenterol 2021;27:144-8. [PMID: 33642351 DOI: 10.4103/sjg.SJG_409_20] [Reference Citation Analysis]
83 Williams AJ, Karimi N, Chari R, Connor S, De Vera MA, Dieleman LA, Hansen T, Ismond K, Khurana R, Kingston D, O'Connor K, Sadowski DC, Fang-Hwa F, Wine E, Leung Y, Huang V. Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid. BMC Gastroenterol 2021;21:302. [PMID: 34330215 DOI: 10.1186/s12876-021-01853-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
84 Croft NM, Faubion WA Jr, Kugathasan S, Kierkus J, Ruemmele FM, Shimizu T, Mostafa NM, Venetucci M, Finney-Hayward T, Sanchez Gonzalez Y, Bereswill M, Lazar A, Turner D. Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study. Lancet Gastroenterol Hepatol 2021;6:616-27. [PMID: 34153231 DOI: 10.1016/S2468-1253(21)00142-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
85 Kurowski JA, Milinovich A, Ji X, Bauman J, Sugano D, Kattan MW, Achkar JP. Differences in Biologic Utilization and Surgery Rates in Pediatric and Adult Crohn's Disease: Results From a Large Electronic Medical Record-derived Cohort. Inflamm Bowel Dis 2021;27:1035-44. [PMID: 32914165 DOI: 10.1093/ibd/izaa239] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
86 Liles E, Irving SA, Dandamudi P, Belongia EA, Daley MF, DeStefano F, Jackson LA, Jacobsen SJ, Kharbanda E, Klein NP, Weintraub E, Naleway AL. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine 2021;39:3614-20. [PMID: 34052066 DOI: 10.1016/j.vaccine.2021.05.032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Zheng HB, de la Morena MT, Suskind DL. The Growing Need to Understand Very Early Onset Inflammatory Bowel Disease. Front Immunol 2021;12:675186. [PMID: 34122435 DOI: 10.3389/fimmu.2021.675186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
88 Kim MJ, Hong SN, Kim YH, Choe YH. [How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?]. Korean J Gastroenterol 2021;77:227-30. [PMID: 34035200 DOI: 10.4166/kjg.2021.065] [Reference Citation Analysis]
89 Dheri AK, Kuenzig ME, Mack DR, Murthy SK, Kaplan GG, Donelle J, Smith G, Benchimol EI. Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada. J Crohns Colitis 2021;15:1991-2000. [PMID: 34019625 DOI: 10.1093/ecco-jcc/jjab095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Benchimol EI, Afif W, Plamondon S, Newhook D, Nicholls SG, Lévesque D. Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care. Journal of the Canadian Association of Gastroenterology 2022;5:3-11. [DOI: 10.1093/jcag/gwab009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Gokli A, Dillman JR, Humphries PD, Ključevšek D, Mentzel HJ, Rubesova E, Takahashi MS, Anupindi SA. Contrast-enhanced ultrasound of the pediatric bowel. Pediatr Radiol 2021. [PMID: 33978797 DOI: 10.1007/s00247-020-04868-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Potthoff LM. Telemedicine and Integrated Multidisciplinary Care for Pediatric IBD Patients: A Review. Children (Basel) 2021;8:347. [PMID: 33924754 DOI: 10.3390/children8050347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 von Graffenried T, Godin JP, Schoepfer A, Breton I, Martin FP, Nydegger A. Body composition assessment in children with inflammatory bowel disease: A comparison of different methods. J Paediatr Child Health 2021;57:1414-9. [PMID: 33847432 DOI: 10.1111/jpc.15491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Dang JT, Dang TT, Wine E, Dicken B, Madsen K, Laffin M. The Genetics of Postoperative Recurrence in Crohn Disease: A Systematic Review, Meta-analysis, and Framework for Future Work. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otaa094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Vernon-roberts A, Gearry RB, Day AS. Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease. GastrointestDisord 2021;3:61-77. [DOI: 10.3390/gidisord3020007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Cheng H, Ma Z, Yu B, Liu X, Tian C, Zhong X, Zhao L. Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument. J Clin Pharm Ther 2021;46:1155-65. [PMID: 33768598 DOI: 10.1111/jcpt.13422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Giannoudaki E, Gargan S, Hussey S, Long A, Walsh PT. Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:640497. [PMID: 33816403 DOI: 10.3389/fped.2021.640497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Ricciuto A, Mack DR, Huynh HQ, Jacobson K, Otley AR, deBruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Jantchou P, Seidman EG, Carman N, Rashid M, Muise A, Wine E, Carroll MW, Lawrence S, Van Limbergen J, Benchimol EI, Walters TD, Griffiths AM, Church PC. Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease. J Crohns Colitis 2021;15:419-31. [PMID: 32978629 DOI: 10.1093/ecco-jcc/jjaa197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
99 Fitzgerald RS, Sanderson IR, Claesson MJ. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. Microb Ecol 2021. [PMID: 33666710 DOI: 10.1007/s00248-021-01697-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
100 Lee A, Moulton D, Mckernan L, Russell A, Slaughter JC, Acra S, Walker L. Clinical Hypnosis in Pediatric Crohn's Disease: A Randomized Controlled Pilot Study. J Pediatr Gastroenterol Nutr 2021;72:e63-70. [PMID: 33538413 DOI: 10.1097/MPG.0000000000002980] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
101 Räisänen L, Viljakainen H, Sarkkola C, Kolho KL. Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases. Eur J Pediatr 2021;180:2115-23. [PMID: 33624160 DOI: 10.1007/s00431-021-03987-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
102 Feingold JH, Kaye-Kauderer H, Mendiolaza M, Dubinsky MC, Keefer L, Gorbenko K. Empowered transitions: Understanding the experience of transitioning from pediatric to adult care among adolescents with inflammatory bowel disease and their parents using photovoice. J Psychosom Res 2021;143:110400. [PMID: 33631616 DOI: 10.1016/j.jpsychores.2021.110400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
103 Bernstein CN, Kuenzig ME, Coward S, Nugent Z, Nasr A, El-Matary W, Singh H, Kaplan GG, Benchimol EI. Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study. J Pediatr 2021;233:98-104.e2. [PMID: 33545193 DOI: 10.1016/j.jpeds.2021.01.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Frias Gomes C, Narula N, Morão B, Nicola P, Cravo M, Torres J. Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease. Dig Dis Sci 2021;66:398-407. [PMID: 32200523 DOI: 10.1007/s10620-020-06204-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Shimizu H, Arai K, Takeuchi I, Minowa K, Hosoi K, Sato M, Oka I, Kaburaki Y, Shimizu T. Long-Term Durability of Infliximab for Pediatric Ulcerative Colitis: A Retrospective Data Review in a Tertiary Children's Hospital in Japan. Pediatr Gastroenterol Hepatol Nutr 2021;24:7-18. [PMID: 33505889 DOI: 10.5223/pghn.2021.24.1.7] [Reference Citation Analysis]
106 Iida C, Tatsumi A, Fujino H, Anzai K, Sumimoto S. Infantile Inflammatory Bowel Disease in a Three-Month-Old-Boy. Cureus 2021;13:e12743. [PMID: 33643722 DOI: 10.7759/cureus.12743] [Reference Citation Analysis]
107 Kumagai H, Kudo T, Uchida K, Kunisaki R, Sugita A, Ohtsuka Y, Arai K, Kubota M, Tajiri H, Suzuki Y, Shimizu T. Transitional care for inflammatory bowel disease: A survey of Japanese pediatric gastroenterologists. Pediatrics International 2021;63:65-71. [DOI: 10.1111/ped.14376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
108 Ho SSC, Keenan JI, Day AS. Parent Perspectives of Diagnostic and Monitoring Tests Undertaken by Their Child with Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2021;24:19-29. [PMID: 33505890 DOI: 10.5223/pghn.2021.24.1.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Kern I, Schoffer O, Kiess W, Henker J, Laaß MW, Winkler U, Quietzsch J, Wenzel O, Zurek M, Büttner K, Fischer P, de Laffolie J, Manuwald U, Stange T, Zenker R, Weidner J, Zimmer KP, Kunath H, Kugler J, Richter T, Rothe U. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry. PLoS One 2021;16:e0243774. [PMID: 33395450 DOI: 10.1371/journal.pone.0243774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
110 Hashimoto-hill S, Kelly D, Alenghat T. Epigenomics of intestinal disease. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00018-9] [Reference Citation Analysis]
111 Kudo T, Arai K, Uchida K, Tajiri H, Hokari R, Suzuki Y, Shimizu T. Very early-onset inflammatory bowel disease in Japan: A nationwide survey. J Gastroenterol Hepatol 2021;36:151-5. [PMID: 32530546 DOI: 10.1111/jgh.15146] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Munden MM, Paltiel HJ. The Gastrointestinal Tract. Pediatric Ultrasound 2021. [DOI: 10.1007/978-3-030-56802-3_10] [Reference Citation Analysis]
113 Takeuchi I, Arai K, Kyodo R, Sato T, Tokita K, Hirano Y, Shimizu H. Ustekinumab for children and adolescents with inflammatory bowel disease at a tertiary children's hospital in Japan. J Gastroenterol Hepatol 2021;36:125-30. [PMID: 32497325 DOI: 10.1111/jgh.15128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
114 Dotson JL, Boyle B. Crohn Disease. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00042-6] [Reference Citation Analysis]
115 Koniushevska AA, Sydorenko NV, Vaizer NV, Kramarenko IE, Yakovenko DV, Bokholdin YО. NON-SPECIFIC ULCER COLITIS IN THE PRACTICE OF A PEDIATRICIAN: ETIOLOGY, PATHOGENESIS, CLASSIFICATION, DIAGNOSIS, TREATMENT (REVIEW OF LITERATURE AND OWN OBSERVATION). VPBM 2021;1:278. [DOI: 10.29254/2077-4214-2021-1-159-278-286] [Reference Citation Analysis]
116 Khosravi F, Ziaeefar P. EARLY AND LONG-TERM OUTCOME OF SURGICAL INTERVENTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE. Arq Bras Cir Dig 2020;33:e1518. [PMID: 33237162 DOI: 10.1590/0102-672020200002e1518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
117 Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN. Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease. Intest Res 2021;19:398-407. [PMID: 33207854 DOI: 10.5217/ir.2020.00107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
118 Kim ES, Kwon Y, Choe YH, Kim MJ. Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients. Sci Rep 2020;10:19032. [PMID: 33149222 DOI: 10.1038/s41598-020-75938-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
119 van Hoeve K, Vermeire S. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Paediatr Drugs 2020;22:449-61. [PMID: 32797366 DOI: 10.1007/s40272-020-00411-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Zheng X, Li M, Wu Y, Lin X, Zhang Z, Zheng W, Wang M. Assessment of pediatric Crohn's disease activity: validation of the magnetic resonance enterography global score (MEGS) against endoscopic activity score (SES-CD). Abdom Radiol (NY) 2020;45:3653-61. [PMID: 32458027 DOI: 10.1007/s00261-020-02590-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Kim ES, Park JH, Choe YH, Kim MJ. Pediatric Crohn's disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature. Intest Res 2021;19:472-7. [PMID: 33108856 DOI: 10.5217/ir.2020.00072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Pruitt LCC, Bucher BT, Allen CM, Short SS. Early ileal pouch anal anastomosis for ulcerative colitis in children: Similar outcome to delayed pouch construction despite higher comorbidity. J Pediatr Surg 2021;56:245-9. [PMID: 33131777 DOI: 10.1016/j.jpedsurg.2020.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
123 Kumagai H, Suzuki Y, Shimizu T. Transitional Care for Patients with Inflammatory Bowel Disease: Japanese Experience. Digestion 2021;102:18-24. [PMID: 33032280 DOI: 10.1159/000510652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
124 Zangara MT, Bhesania N, Liu W, Cresci GAM, Kurowski JA, Mcdonald C. Impact of Diet on Inflammatory Bowel Disease Symptoms: An Adolescent Viewpoint. Crohn's & Colitis 360 2020;2. [DOI: 10.1093/crocol/otaa084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Qualter P, Rouncefield-Swales A, Bray L, Blake L, Allen S, Probert C, Crook K, Carter B. Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition. Qual Life Res 2021;30:497-506. [PMID: 32997335 DOI: 10.1007/s11136-020-02653-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
126 Kuenzig ME, Benchimol EI. Cancer in Children with Inflammatory Bowel Disease: Are We Making a Difference? J Pediatr 2021;229:11-2. [PMID: 32971145 DOI: 10.1016/j.jpeds.2020.09.046] [Reference Citation Analysis]
127 Xinias I, Mavroudi A, Tsarouchas A, Mouselimis D, Karanika P, Agakidis C, Vasilaki K, Giouleme O. Inflammatory Bowel Disease in Children and Adolescents - a Retrospective Study of 13 Years of Records Investigating Potential Prognostic Factors. Maedica (Bucur) 2020;15:146-54. [PMID: 32952677 DOI: 10.26574/maedica.2020.15.2.146] [Reference Citation Analysis]
128 Chan KJ, Song ZL, Chew KS, Ng RT, Mohd Taib SH, Lee WS. Exclusive enteral nutrition is effective and feasible as primary induction and re-induction therapy in Asian children with Crohn's disease. J Paediatr Child Health 2021;57:239-45. [PMID: 32936506 DOI: 10.1111/jpc.15184] [Reference Citation Analysis]
129 Laube R, Yau Y, Selinger CP, Seow CH, Thomas A, Wei Chuah S, Hilmi I, Mao R, Ong D, Ng SC, Chen Wei S, Banerjee R, Ahuja V, Alharbi O, Leong RW. Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre Study. J Crohns Colitis 2020;14:1248-55. [PMID: 32191292 DOI: 10.1093/ecco-jcc/jjaa047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
130 Roberts SE, Thorne K, Thapar N, Broekaert I, Benninga MA, Dolinsek J, Mas E, Miele E, Orel R, Pienar C, Ribes-Koninckx C, Thomson M, Tzivinikos C, Morrison-Rees S, John A, Williams JG. A Systematic Review and Meta-analysis of Paediatric Inflammatory Bowel Disease Incidence and Prevalence Across Europe. J Crohns Colitis 2020;14:1119-48. [PMID: 32115645 DOI: 10.1093/ecco-jcc/jjaa037] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
131 Iwańczak B, Ruczka M, Matusiewicz M, Pytrus T, Matusiewicz K, Krzesiek E. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children. Adv Med Sci 2020;65:259-64. [PMID: 32361483 DOI: 10.1016/j.advms.2020.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
132 Burnett D, Brown MM, Otley A, Kuhle S. The Association Between Caesarean Section and Inflammatory Bowel Disease in Childhood and Young Adulthood: Findings From 2 Retrospective Cohort Studies. J Pediatr Gastroenterol Nutr 2020;71:e84-9. [PMID: 32404757 DOI: 10.1097/MPG.0000000000002773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Banerjee R, Pal P, Nugent Z, Ganesh G, Adigopula B, Pendyala S, Bernstein CN. IBD in India: Similar Phenotype but Different Demographics Than the West. J Clin Gastroenterol 2020;54:725-32. [PMID: 31770158 DOI: 10.1097/MCG.0000000000001282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
134 Michel HK, Siripong N, Noll RB, Kim SC. Caregiver and Adolescent Patient Perspectives on Comprehensive Care for Inflammatory Bowel Diseases: Building a Family-Centered Care Delivery Model. Crohns Colitis 360 2020;2:otaa055. [PMID: 32851385 DOI: 10.1093/crocol/otaa055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
135 Arai K. Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists. Pediatr Gastroenterol Hepatol Nutr 2020;23:411-22. [PMID: 32953636 DOI: 10.5223/pghn.2020.23.5.411] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
136 Baig A, Avlasevich SL, Torous DK, Bemis JC, Saubermann LJ, Lovell DP, MacGregor JT, Dertinger SD. Assessment of systemic genetic damage in pediatric inflammatory bowel disease. Environ Mol Mutagen 2020;61:901-9. [PMID: 32761646 DOI: 10.1002/em.22403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults. J Can Assoc Gastroenterol 2021;4:186-93. [PMID: 34337319 DOI: 10.1093/jcag/gwaa028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
138 Martinelli M, Giugliano FP, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, Navas-López VM, Romano C, Sladek M, Veres G, Aloi M, Kucinskiene R, Miele E. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflamm Bowel Dis 2020;26:1407-14. [PMID: 31689349 DOI: 10.1093/ibd/izz264] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
139 Arai K, Kunisaki R, Kakuta F, Hagiwara SI, Murakoshi T, Yanagi T, Shimizu T, Kato S, Ishige T, Aomatsu T, Inoue M, Saito T, Iwama I, Kawashima H, Kumagai H, Tajiri H, Iwata N, Mochizuki T, Noguchi A, Kashiwabara T, Shimizu H, Suzuki Y, Hirano Y, Fujiwara T. Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry. Intest Res 2020;18:412-20. [PMID: 32806870 DOI: 10.5217/ir.2019.00130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
140 El Mouzan M, Alahmadi N, ALSaleeem KA, Assiri A, AlSaleem B, Al Sarkhy A. Prevalence of nutritional disorders in Saudi children with inflammatory bowel disease based on the national growth reference. Arab J Gastroenterol 2020;21:179-82. [PMID: 32798189 DOI: 10.1016/j.ajg.2020.07.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Martin NG, Roberts AJ, Evans HM, Bishop J, Day AS. Three-year outcomes of childhood inflammatory bowel disease in New Zealand: A population-based cohort study. JGH Open 2020;4:642-8. [PMID: 32782951 DOI: 10.1002/jgh3.12310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Zabrowski D, Abraham D, Rosenthal G, Kader H. Development of peripheral eosinophilia in inflammatory bowel disease patients on infliximab treated at a tertiary pediatric inflammatory bowel disease center is associated with clinically active disease but does not result in loss of efficacy or adverse outcomes. JGH Open 2020;4:636-41. [PMID: 32782950 DOI: 10.1002/jgh3.12308] [Reference Citation Analysis]
143 Nakano A, Hashimoto N, Takata K, Iida Y, Takagawa K, Sakai T, Mushiake S. A case of microscopic colitis diagnosed by endoscopy during oral immunotherapy. Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunollogy 2020;34:339-345. [DOI: 10.3388/jspaci.34.339] [Reference Citation Analysis]
144 Bashir NS, Walters TD, Griffiths AM, Ito S, Ungar WJ. Cost-effectiveness and Clinical Outcomes of Early Anti-Tumor Necrosis Factor-α Intervention in Pediatric Crohn's Disease. Inflamm Bowel Dis 2020;26:1239-50. [PMID: 31728510 DOI: 10.1093/ibd/izz267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
145 Kang B, Kim TJ, Choi J, Baek SY, Ahn S, Choi R, Lee SY, Choe YH. Adjustment of azathioprine dose should be based on a lower 6-TGN target level to avoid leucopenia in NUDT15 intermediate metabolisers. Aliment Pharmacol Ther 2020;52:459-70. [PMID: 32598049 DOI: 10.1111/apt.15810] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
146 Kia SJ, Mansourian A, Basirat M, Akhavan M, Mohtasham-amiri Z, Moosavi M. New concentration of curcumin orabase in recurrent aphthous stomatitis: A randomized, controlled clinical trial. Journal of Herbal Medicine 2020;22:100336. [DOI: 10.1016/j.hermed.2020.100336] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
147 Carter B, Roland D, Bray L, Harris J, Pandey P, Fox J, Carrol ED, Neill S. A systematic review of the organizational, environmental, professional and child and family factors influencing the timing of admission to hospital for children with serious infectious illness. PLoS One 2020;15:e0236013. [PMID: 32702034 DOI: 10.1371/journal.pone.0236013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
148 Pasvol TJ, Horsfall L, Bloom S, Segal AW, Sabin C, Field N, Rait G. Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study. BMJ Open 2020;10:e036584. [PMID: 32690524 DOI: 10.1136/bmjopen-2019-036584] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
149 Niehues T, Özgür TT. The Efficacy and Evidence-Based Use of Biologics in Children and Adolescents: Using Monoclonal Antibodies and Fusion Proteins as Treatments. Dtsch Arztebl Int 2019;116:703-10. [PMID: 31711560 DOI: 10.3238/arztebl.2019.0703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
150 Tatsuki M, Ishige T, Igarashi Y, Hatori R, Hokama A, Hirato J, Muise A, Takizawa T, Arakawa H. Whipple disease mimicking inflammatory bowel disease. Intest Res 2021;19:119-25. [PMID: 32610889 DOI: 10.5217/ir.2019.09177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
151 Michel HK, Noll RB, Siripong N, Kim SC. Patterns of Primary, Specialty, Urgent Care, and Emergency Department Care in Children With Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2020;71:e28-34. [PMID: 32142000 DOI: 10.1097/MPG.0000000000002703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Wang L, Xue A, Zheng C, Zhou Y, Wang Y, Huang Y. Long-term outcomes of thalidomide in pediatric Crohn's disease. J Gastroenterol Hepatol 2020;35:1124-9. [PMID: 31758718 DOI: 10.1111/jgh.14939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
153 Jabandziev P, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:985-93. [PMID: 32009179 DOI: 10.1093/ibd/izaa009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
154 Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Russell RK, Walters TD, Ruemmele FM, Samsom JN, Croft NM, de Ridder L; PIBD-SETQuality consortium and PIBD-NET. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open 2020;10:e035538. [PMID: 32611739 DOI: 10.1136/bmjopen-2019-035538] [Reference Citation Analysis]
155 Dhaliwal J, Martincevic I, Williams B, Frost K, Uusoue K, Arpino V, Church P, Walters TD, Griffiths AM, Mouzaki M. Body Composition Using Air Displacement Plethysmography in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:52-8. [PMID: 32141991 DOI: 10.1097/MPG.0000000000002683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
156 Barbiellini Amidei C, Zingone F, Zanier L, Canova C. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study. Int J Environ Res Public Health 2020;17:E4255. [PMID: 32549223 DOI: 10.3390/ijerph17124255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
157 Carter B, Rouncefield-Swales A, Bray L, Blake L, Allen S, Probert C, Crook K, Qualter P. "I Don't Like to Make a Big Thing out of It": A Qualitative Interview-Based Study Exploring Factors Affecting Whether Young People Tell or Do Not Tell Their Friends about Their IBD. Int J Chronic Dis 2020;2020:1059025. [PMID: 32577420 DOI: 10.1155/2020/1059025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
158 Green N, Lee D, Wahbeh G, Pacheco MC. Do Histologic Features Help Predict Colectomy in Pediatric Patients Presenting With Acute Severe Colitis? Pediatr Dev Pathol 2020;23:380-6. [PMID: 32511053 DOI: 10.1177/1093526620929477] [Reference Citation Analysis]
159 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
160 Michel HK, Kim SC, Siripong N, Noll RB. Gaps Exist in the Comprehensive Care of Children with Inflammatory Bowel Diseases. J Pediatr 2020;224:94-101. [PMID: 32482390 DOI: 10.1016/j.jpeds.2020.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
161 Bae J, Choe BH, Kang B. Prevention of thiopurine-induced early leukopenia in a Korean pediatric patient with Crohn's disease who turned out to possess homozygous mutations in NUDT15 R139C. Yeungnam Univ J Med 2020;37:332-6. [PMID: 32438538 DOI: 10.12701/yujm.2020.00178] [Reference Citation Analysis]
162 Dhaliwal J, Walters TD, Mack DR, Huynh HQ, Jacobson K, Otley AR, Debruyn J, El-Matary W, Deslandres C, Sherlock ME, Critch JN, Bax K, Seidman E, Jantchou P, Ricciuto A, Rashid M, Muise AM, Wine E, Carroll M, Lawrence S, Van Limbergen J, Benchimol EI, Church P, Griffiths AM. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network. J Crohns Colitis 2020;14:445-54. [PMID: 31136648 DOI: 10.1093/ecco-jcc/jjz106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
163 Sandberg K, Yarger E, Saeed S. Updates in diagnosis and management of inflammatory bowel disease.Curr Probl Pediatr Adolesc Health Care. 2020;50:100785. [PMID: 32402535 DOI: 10.1016/j.cppeds.2020.100785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
164 Silva LC, Seixas RBPM, de Carvalho E. Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors. Pediatr Gastroenterol Hepatol Nutr 2020;23:286-96. [PMID: 32483550 DOI: 10.5223/pghn.2020.23.3.286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
165 Nardone OM, Iacucci M, Ghosh S, Castiglione F. Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? Dig Liver Dis 2020;52:516-27. [PMID: 32234418 DOI: 10.1016/j.dld.2020.02.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
166 Raman M, Morell A, Ali S. Severe Microcytic Anemia and Chronic Abdominal Pain in a Pediatric Patient. Clin Pediatr (Phila) 2020;59:536-539. [DOI: 10.1177/0009922819901014] [Reference Citation Analysis]
167 Jabandziev P, Pinkasova T, Kunovsky L, Papez J, Jouza M, Karlinova B, Novackova M, Urik M, Aulicka S, Slaby O, Bohosova J, Bajerova K, Bajer M, Goel A. Regional Incidence of Inflammatory Bowel Disease in a Czech Pediatric Population: 16 Years of Experience (2002-2017). J Pediatr Gastroenterol Nutr 2020;70:586-92. [PMID: 32058417 DOI: 10.1097/MPG.0000000000002660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
168 El Mouzan MI, AlSaleem BI, Hasosah MY, Al-Hussaini AA, Al Anazi AH, Saadah OI, Al Sarkhy AA, Al Mofarreh MA, Assiri AA. Diagnostic delay of pediatric inflammatory bowel disease in Saudi Arabia. Saudi J Gastroenterol 2019;25:257-61. [PMID: 30971589 DOI: 10.4103/sjg.SJG_457_18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
169 Cohen A, Ahmed N, Sant'Anna A. Ustekinumab for the treatment of refractory pediatric Crohn's disease: a single-center experience. Intest Res 2021;19:217-24. [PMID: 32312033 DOI: 10.5217/ir.2019.09164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
170 Canova C, Ludvigsson JF, Di Domenicantonio R, Zanier L, Barbiellini Amidei C, Zingone F. Perinatal and Antibiotic Exposures and the Risk of Developing Childhood-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Based on a Population-Based Birth Cohort. Int J Environ Res Public Health 2020;17:E2409. [PMID: 32252276 DOI: 10.3390/ijerph17072409] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
171 Mouratidou N, Malmborg P, Sachs MC, Askling J, Ekbom A, Neovius M, Smedby KE, Sävendahl L, Ludvigsson JF, Olén O. Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study. Aliment Pharmacol Ther 2020;51:789-800. [PMID: 32133656 DOI: 10.1111/apt.15667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
172 Takeuchi I, Kaburaki Y, Arai K, Shimizu H, Hirano Y, Nagata S, Shimizu T. Infliximab for very early-onset inflammatory bowel disease: A tertiary center experience in Japan. J Gastroenterol Hepatol 2020;35:593-600. [PMID: 31425641 DOI: 10.1111/jgh.14836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
173 Fondell AW, Mosha MH, Frank CR, Brangi JM, Hyams JS. Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:635-40. [PMID: 31504513 DOI: 10.1093/ibd/izz183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
174 Kowalska-Duplaga K, Kapusta P, Gosiewski T, Sroka-Oleksiak A, Ludwig-Słomczyńska AH, Wołkow PP, Fyderek K. Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn's Disease. J Clin Med 2020;9:E687. [PMID: 32143438 DOI: 10.3390/jcm9030687] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
175 Lopez RN, McCombie A, Gearry RB, Day AS. Impact of a Camp upon Disease-Specific Knowledge and Quality of Life in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Intest Dis 2020;5:65-9. [PMID: 32596256 DOI: 10.1159/000505918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
176 Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Karaminejadranjbar M, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM, Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA; COLORS in IBD group investigators., Oxford IBD cohort study investigators., INTERVAL Study., Swiss IBD cohort investigators., UK IBD Genetics Consortium., NIDDK IBD Genetics Consortium. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nat Commun 2020;11:995. [PMID: 32081864 DOI: 10.1038/s41467-019-14275-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
177 de Laffolie J. Epidemiologische Forschung und Behandlungsdatenanalyse zu chronisch-entzündlichen Darmerkrankungen: Verbesserung der Versorgung von Kindern und Jugendlichen. Monatsschr Kinderheilkd 2020;168:298-313. [DOI: 10.1007/s00112-020-00852-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
178 Grob L, Bluemel S, Biedermann L, Fournier N, Rossel JB, Vavricka SR, Zeitz J, Rogler G, Stallmach A, Scharl M. Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study. Therap Adv Gastroenterol 2020;13:1756284819895217. [PMID: 32047533 DOI: 10.1177/1756284819895217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
179 Li X, Lee EJ, Gawel DR, Lilja S, Schäfer S, Zhang H, Benson M. Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis. J Immunol Res 2020;2020:8279619. [PMID: 32411805 DOI: 10.1155/2020/8279619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
180 Bonati M. Transitioning youth to adult age also through health services. Epidemiol Psychiatr Sci 2020;29:e88. [PMID: 31915105 DOI: 10.1017/S2045796019000842] [Reference Citation Analysis]
181 El-Matary W, Kuenzig ME, Singh H, Okoli G, Moghareh M, Kumar H, Lê ML, Benchimol EI. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis 2020;26:206-15. [PMID: 31211827 DOI: 10.1093/ibd/izz120] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
182 Menchini CB. Pediatric Inflammatory Bowel Disease Complications Are More Likely on the Weekend. Inflamm Bowel Dis 2020;26:261-2. [PMID: 31247069 DOI: 10.1093/ibd/izz140] [Reference Citation Analysis]
183 Isaac DM, Wine E. Crohn's Disease, Pediatric. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65899-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
184 Yoshida T, Malherbe CJ, Okon K, Miura Y, Hattori M, Matsuda H, Muller CJ, Joubert E. Enhanced production of Th1- and Th2-type antibodies and induction of regulatory T cells in mice by oral administration of Cyclopia extracts with similar phenolic composition to honeybush herbal tea. Journal of Functional Foods 2020;64:103704. [DOI: 10.1016/j.jff.2019.103704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
185 Plevinsky JM, Greenley RN. Inflammatory bowel disease and gastrointestinal disorders. Adherence and Self-Management in Pediatric Populations 2020. [DOI: 10.1016/b978-0-12-816000-8.00011-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
186 Wahbeh GT, Bradshaw A, White L, Lee D. Gastrointestinal and Hepatic Issues in Women with Turner Syndrome. Turner Syndrome 2020. [DOI: 10.1007/978-3-030-34150-3_12] [Reference Citation Analysis]
187 Elgazzar AH, Alenezi S. Nuclear Medicine in the Digestive System. A Concise Guide to Nuclear Medicine 2020. [DOI: 10.1007/978-3-030-26064-4_3] [Reference Citation Analysis]
188 . Nutrition in the Management of Chronic Autoimmune Inflammatory Bowel Diseases in Children. Pediatric Nutrition 2020. [DOI: 10.1542/9781610023610-42] [Reference Citation Analysis]
189 Crowley E, Muise AM. Pediatric Diarrheal Disorders. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65901-9] [Reference Citation Analysis]
190 Timmer A. Epidemiologie der chronisch-entzündlichen Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_2] [Reference Citation Analysis]
191 Huang JG, Aw MM. Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history. Pediatr Neonatol 2020;61:263-71. [PMID: 32005607 DOI: 10.1016/j.pedneo.2019.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
192 Gurram B, Patel AS. Recent advances in understanding and managing pediatric inflammatory bowel disease. F1000Res 2019;8:2097. [DOI: 10.12688/f1000research.19609.1] [Reference Citation Analysis]
193 McVeigh L, Payne A. Inducing remission in paediatric Crohn's disease using nutritional therapies - A systematic review. J Hum Nutr Diet 2020;33:170-86. [PMID: 31797471 DOI: 10.1111/jhn.12714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
194 Keyashian K, Dehghan M, Sceats L, Kin C, Limketkai BN, Park KT. Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States. Inflamm Bowel Dis 2019;25:1983-9. [PMID: 31095681 DOI: 10.1093/ibd/izz092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
195 Patel T, Grossman AB. Updates in Healthcare Maintenance and Monitoring of Children with Inflammatory Bowel Disease in the Era of Biologic Therapies. Curr Treat Options Peds 2019;5:466-482. [DOI: 10.1007/s40746-019-00181-4] [Reference Citation Analysis]
196 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis 2019;25:1927-38. [PMID: 31276165 DOI: 10.1093/ibd/izz130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
197 Fuller MK. Pediatric Inflammatory Bowel Disease. Surgical Clinics of North America 2019;99:1177-83. [DOI: 10.1016/j.suc.2019.08.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
198 Cousin C, Bevilacqua C, Roman C, Roquelaure B, Loundou A, Baumstarck K, Fabre A. MICI-MINOTS: Linguistic and metric validation of a pediatric questionnaire on knowledge about inflammatory bowel disease. Arch Pediatr. 2020;27:110-116. [PMID: 31796231 DOI: 10.1016/j.arcped.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
199 Pai N, Popov J, Hill L, Hartung E. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial. BMJ Open 2019;9:e030120. [PMID: 31784432 DOI: 10.1136/bmjopen-2019-030120] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
200 Schwartz NRM, Hutfless S, Herrinton LJ, Amsden LB, Fevrier HB, Giefer M, Lee D, Suskind DL, Delaney JAC, Phipps AI. Proton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children. J Pediatr Pharmacol Ther 2019;24:489-96. [PMID: 31719810 DOI: 10.5863/1551-6776-24.6.489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
201 Derderian SC, Phillips R, Acker SN, Bruny J, Partrick DA. Pediatric ulcerative colitis: three- versus two-stage colectomy with ileal pouch-anal anastomosis. Pediatr Surg Int 2020;36:171-7. [DOI: 10.1007/s00383-019-04595-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
202 Lund K, Larsen MD, Knudsen T, Kjeldsen J, Nielsen RG, Nørgård BM. The impact of anti-TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015. Aliment Pharmacol Ther 2019;50:1077-85. [PMID: 31579961 DOI: 10.1111/apt.15510] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
203 Jerger L, Hyams JS. Special considerations for biologic medications in pediatric ulcerative colitis. Expert Opin Biol Ther 2020;20:429-35. [PMID: 31652087 DOI: 10.1080/14712598.2020.1685492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
204 Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults. Front Pediatr 2019;7:432. [PMID: 31709203 DOI: 10.3389/fped.2019.00432] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
205 Metzger CE, Narayanan SA, Elizondo JP, Carter AM, Zawieja DC, Hogan HA, Bloomfield SA. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone. Sci Rep 2019;9:15144. [PMID: 31641205 DOI: 10.1038/s41598-019-51550-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
206 Goldiș A, Lupușoru R, Gheorghe L, Gheorghe C, Trifan A, Dobru D, Cijevschi C, Tanțău A, Constantinescu G, Iacob R, Goldiș R, Diculescu M. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania. Medicina (Kaunas) 2019;55:E704. [PMID: 31635181 DOI: 10.3390/medicina55100704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 Nameirakpam J, Rikhi R, Rawat SS, Sharma J, Suri D. Genetics on early onset inflammatory bowel disease: An update. Genes Dis 2020;7:93-106. [PMID: 32181280 DOI: 10.1016/j.gendis.2019.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
208 Tang WJ, Shi P, Zheng CF, Shi JR, Qiu XX, Wang SN, Huang Y. Special clinical characteristics and outcomes in Chinese pediatric patients with early-onset Crohn's disease. J Dig Dis 2019;20:539-46. [PMID: 31347264 DOI: 10.1111/1751-2980.12803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
209 Senbanjo I, Akinola A, Kumolu-Johnson T, Igbekoyi O, Oshikoya K. Inflammatory bowel disease in Nigerian children: case series and management challenges. Paediatr Int Child Health 2020;40:143-7. [PMID: 31495301 DOI: 10.1080/20469047.2019.1662658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
210 Vitebskaya AV, Popovich AV, Afonina EY, Kostina YO, Aleksanyan KV, Grammatopulo MI, Yablokova EA, Shpitonkova OV. Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids. Diabetes mellitus 2019;22:263-273. [DOI: 10.14341/dm10042] [Reference Citation Analysis]
211 Brooks AJ, Norman P, Peach EJ, Ryder A, Scott AJ, Narula P, Corfe BM, Lobo AJ, Rowse G. Prospective Study of Psychological Morbidity and Illness Perceptions in Young People With Inflammatory Bowel Disease. J Crohns Colitis 2019;13:1003-11. [PMID: 30722006 DOI: 10.1093/ecco-jcc/jjz028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
212 Marafini I, Sedda S, Dinallo V, Monteleone G. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opin Biol Ther 2019;19:1207-17. [PMID: 31373244 DOI: 10.1080/14712598.2019.1652267] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
213 Jakate A, McNamee B, Burkindine D. Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers. Clin Pharmacol 2019;11:93-101. [PMID: 31372067 DOI: 10.2147/CPAA.S193191] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019;21:40. [PMID: 31338613 DOI: 10.1007/s11894-019-0705-6] [Cited by in Crossref: 108] [Cited by in F6Publishing: 84] [Article Influence: 27.0] [Reference Citation Analysis]
215 Schütz L, Radke M, Menzel S, Däbritz J. Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study. BMC Gastroenterol 2019;19:128. [PMID: 31324228 DOI: 10.1186/s12876-019-1046-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
216 Hakim A, Alexakis C, Pilcher J, Tzias D, Mitton S, Paul T, Saxena S, Pollok R, Kumar S. Comparison of small intestinal contrast ultrasound with magnetic resonance enterography in pediatric Crohn's disease. JGH Open 2020;4:126-31. [PMID: 32280754 DOI: 10.1002/jgh3.12228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
217 Habernig S, Malle P, Hausegger KA. [Inflammatory gastrointestinal diseases in children : Radiological diagnosis]. Radiologe 2018;58:326-33. [PMID: 29476194 DOI: 10.1007/s00117-018-0370-z] [Reference Citation Analysis]
218 Carchman E. Crohn's Disease and the Risk of Cancer. Clin Colon Rectal Surg 2019;32:305-13. [PMID: 31275078 DOI: 10.1055/s-0039-1683923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
219 Kellar A, Wilson S, Kaplan G, DeBruyn J, Tanyingoh D, Novak KL. The Simple Pediatric Activity Ultrasound Score (SPAUSS) for the Accurate Detection of Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:e1-6. [PMID: 31232886 DOI: 10.1097/MPG.0000000000002298] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
220 Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS. Response pattern analysis of IBD-KID: A knowledge assessment tool for children with inflammatory bowel disease. J Paediatr Child Health. 2020;56:155-162. [PMID: 31243856 DOI: 10.1111/jpc.14547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
221 Wasielewska Z, Dolińska A, Wilczyńska D, Szaflarska-Popławska A, Krogulska A. Prevalence of allergic diseases in children with inflammatory bowel disease. Postepy Dermatol Alergol 2019;36:282-90. [PMID: 31333345 DOI: 10.5114/ada.2018.81189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
222 Capone K, Rosenberg HJ, Wroblewski K, Gokhale R, Kirschner BS. Change in Prevalence of Family History During Long-term Follow-up of Patients With Pediatric-onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:829-34. [PMID: 30628987 DOI: 10.1097/MPG.0000000000002253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
223 Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, Hellstrom WJG, Palmert MR, Corona G, Dohle GR, Khera M, Chan YM, Maggi M. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers 2019;5:38. [PMID: 31147553 DOI: 10.1038/s41572-019-0087-y] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 25.3] [Reference Citation Analysis]
224 Li J, Zhao X, Li X, Lu M, Zhang H. Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis. Mediators Inflamm. 2019;2019:2136501. [PMID: 31275056 DOI: 10.1155/2019/2136501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
225 Turner D. Particularities of IBD Trials in Children. CPD 2019;25:69-72. [DOI: 10.2174/1381612825666190307125511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
226 Aardoom MA, Veereman G, de Ridder L. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E2529. [PMID: 31126015 DOI: 10.3390/ijms20102529] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 9.3] [Reference Citation Analysis]
227 Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA. Challenges in IBD Research: Pragmatic Clinical Research. Inflamm Bowel Dis 2019;25:S40-7. [PMID: 31095704 DOI: 10.1093/ibd/izz085] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
228 Walker R, Kammermeier J, Vora R, Mutalib M. Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all? Ann Gastroenterol 2019;32:387-91. [PMID: 31263361 DOI: 10.20524/aog.2019.0381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol 2019;16:296-311. [PMID: 30787446 DOI: 10.1038/s41575-019-0118-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
230 Bourdier P, Saidi O, Rochette E, Ratel S, Merlin E, Pereira B, Duché P. Physical activity and sedentary levels in children with juvenile idiopathic arthritis and inflammatory bowel disease. A systematic review and meta-analysis. Pediatr Res 2019;86:149-56. [PMID: 31029060 DOI: 10.1038/s41390-019-0409-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
231 Rabe H, Malmquist M, Barkman C, Östman S, Gjertsson I, Saalman R, Wold AE. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease. Clin Exp Immunol 2019;197:111-29. [PMID: 30883691 DOI: 10.1111/cei.13294] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
232 Correal EN, Leiva OB, Galguera AD, Barrero MG, Pastor ES, Gonzalo MFM. Nurse-Led Telephone Advice Line for Patients With Inflammatory Bowel Disease: A Cross-Sectional Multicenter Activity Analysis. Gastroenterol Nurs 2019;42:133-9. [PMID: 30946300 DOI: 10.1097/SGA.0000000000000372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
233 Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG. Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. Gastroenterology 2019;156:1345-1353.e4. [PMID: 30639677 DOI: 10.1053/j.gastro.2019.01.002] [Cited by in Crossref: 176] [Cited by in F6Publishing: 176] [Article Influence: 44.0] [Reference Citation Analysis]
234 Fumery M, Pariente B, Sarter H, Savoye G, Spyckerelle C, Djeddi D, Mouterde O, Bouguen G, Ley D, Peneau A, Dupas JL, Turck D, Gower-Rousseau C; Epimad Group. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study. Dig Liver Dis 2019;51:496-502. [PMID: 30611597 DOI: 10.1016/j.dld.2018.11.033] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
235 Kumar SS, Sindgikar SP, Shenoy V, Sinha S, Shankar R. PEDIATRIC CROHN DISEASE: A CASE SERIES FROM A TERTIARY CARE CENTER. IJCH 2019;6:133-135. [DOI: 10.32677/ijch.2019.v06.i03.009] [Reference Citation Analysis]
236 Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol 2019; 25(12): 1465-1477 [PMID: 30948910 DOI: 10.3748/wjg.v25.i12.1465] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
237 Dalzell AM, Ba’ath ME. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 2019;39:48-58. [DOI: 10.1080/20469047.2019.1575056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
238 Day AS. Inflammatory bowel disease in children. Transl Pediatr 2019;8:1-3. [PMID: 30881892 DOI: 10.21037/tp.2019.01.05] [Reference Citation Analysis]
239 Karim S, Porter JA, McCombie A, Gearry RB, Day AS. Transition clinics: an observational study of themes important to young people with inflammatory bowel disease. Transl Pediatr 2019;8:83-9. [PMID: 30881902 DOI: 10.21037/tp.2019.01.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
240 Hagiwara SI, Kudo T, Kakuta F, Inoue M, Yokoyama K, Umetsu S, Iwama I, Yodoshi T, Tatsuki M, Shimizu T, Nakayama Y. Clinical Safety and Utility of Pediatric Balloon-assisted Enteroscopy: A Multicenter Prospective Study in Japan. J Pediatr Gastroenterol Nutr 2019;68:306-10. [PMID: 30444835 DOI: 10.1097/MPG.0000000000002181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
241 Ghersin I, Khteeb N, Katz LH, Daher S, Shamir R, Assa A. Trends in the epidemiology of inflammatory bowel disease among Jewish Israeli adolescents: a population-based study. Aliment Pharmacol Ther 2019;49:556-63. [PMID: 30687945 DOI: 10.1111/apt.15160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
242 Miller SD, Cuffari C, Akhuemonkhan E, Guerrerio AL, Lehmann H, Hutfless S. Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010-2014. Pediatr Gastroenterol Hepatol Nutr 2019;22:152-61. [PMID: 30899691 DOI: 10.5223/pghn.2019.22.2.152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
243 Halbmeijer N, Groeneweg M, De Ridder L. Cannabis, a potential treatment option in pediatric IBD? Still a long way to go. Expert Rev Clin Pharmacol 2019;12:355-61. [PMID: 30767696 DOI: 10.1080/17512433.2019.1582330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
244 Fritz J, Walia C, Elkadri A, Pipkorn R, Dunn RK, Sieracki R, Goday PS, Cabrera JM. A Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:445-59. [PMID: 30137322 DOI: 10.1093/ibd/izy271] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
245 Schooler GR, Hull NC, Mavis A, Lee EY. MR Imaging Evaluation of Inflammatory Bowel Disease in Children:: Where Are We Now in 2019. Magn Reson Imaging Clin N Am 2019;27:291-300. [PMID: 30910099 DOI: 10.1016/j.mric.2019.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
246 Otto C, Tárnok A, Erős A, Szakács Z, Vincze Á, Farkas N, Sarlós P. Planned Transition of Adolescent Patients with Inflammatory Bowel Disease Results in Higher Remission Rates. J Pediatr Nurs 2019;45:62-6. [PMID: 30745207 DOI: 10.1016/j.pedn.2019.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
247 Maccioni F, Bencardino D, Buonocore V, Mazzamurro F, Viola F, Oliva S, Vernia P, Merli M, Vestri AR, Catalano C, Cucchiara S. MRI reveals different Crohn's disease phenotypes in children and adults. Eur Radiol. 2019;29:5082-5092. [PMID: 30729332 DOI: 10.1007/s00330-019-6006-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
248 Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU. Aliment Pharmacol Ther 2019;49:419-28. [PMID: 30637837 DOI: 10.1111/apt.15114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
249 Wittig R, Albers L, Koletzko S, Saam J, von Kries R. Pediatric Chronic Inflammatory Bowel Disease in a German Statutory Health INSURANCE-Incidence Rates From 2009 to 2012. J Pediatr Gastroenterol Nutr 2019;68:244-50. [PMID: 30672768 DOI: 10.1097/MPG.0000000000002162] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
250 Rigterink T, Appleton L, Day AS. Vitamin D therapy in children with inflammatory bowel disease: A systematic review. World J Clin Pediatr 2019; 8(1): 1-14 [PMID: 30697514 DOI: 10.5409/wjcp.v8.i1.1] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
251 Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis. World J Pediatr. 2019;15:26-36. [PMID: 30666565 DOI: 10.1007/s12519-018-0204-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
252 Tarnok A, Kiss Z, Kadenczki O, Veres G. Characteristics of biological therapy in pediatric patients with Crohn's disease. Expert Opin Biol Ther 2019;19:181-96. [PMID: 30601083 DOI: 10.1080/14712598.2019.1564034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
253 Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22:50-56. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
254 Kim J, Ye BD. Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key? Pediatr Gastroenterol Hepatol Nutr 2019;22:28-40. [PMID: 30671371 DOI: 10.5223/pghn.2019.22.1.28] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
255 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
256 Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
257 Litvinova EA, Achasova KM, Borisova MA, Zhenilo SV, Prokhortchouk EB, Kozhevnikova EN. Role of the Kaiso gene in the development of inflammation in Mucin-2 defcient mice. Vestn VOGiS 2019;22:1078-83. [DOI: 10.18699/vj18.453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
258 Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group. Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience. Biologics 2019;13:13-21. [PMID: 30655661 DOI: 10.2147/BTT.S183088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
259 Muise AM. Very Early Onset Inflammatory Bowel Disease (VEOIBD). Textbook of Autoinflammation 2019. [DOI: 10.1007/978-3-319-98605-0_21] [Reference Citation Analysis]
260 Garrick V. Young IBD. Inflammatory Bowel Disease Nursing Manual 2019. [DOI: 10.1007/978-3-319-75022-4_25] [Reference Citation Analysis]
261 Mattioli G, Wong MCY, Faticato MG. Minimal-Access Colorectal Surgery in Pediatric Age. ESPES Manual of Pediatric Minimally Invasive Surgery 2019. [DOI: 10.1007/978-3-030-00964-9_47] [Reference Citation Analysis]
262 Polishchuk TV. DISEASES OF GASTROINTESTINAL TRACT IN ORAL CAVITY OF CHILDREN. VPBM 2019;2.1:55. [DOI: 10.29254/2077-4214-2019-2-1-150-55-59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
263 Kim S, Park S, Kang Y, Kwon N, Koh H. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease. Acta Paediatr 2019;108:138-42. [PMID: 29998507 DOI: 10.1111/apa.14498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
264 Mandelia C, Shen B, Mahajan L. Ileal Pouch in Children. Pouchitis and Ileal Pouch Disorders 2019. [DOI: 10.1016/b978-0-12-809402-0.00007-1] [Reference Citation Analysis]
265 Lang T, Ure B, Melter M. Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen. Kinderchirurgie 2019. [DOI: 10.1007/978-3-662-58202-2_57] [Reference Citation Analysis]
266 Stenke E, Bourke B, Knaus UG. NAPDH Oxidases in Inflammatory Bowel Disease. Methods Mol Biol 2019;1982:695-713. [PMID: 31172500 DOI: 10.1007/978-1-4939-9424-3_38] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
267 Messaris E, Dassopoulos T. Concepts in Inflammatory Bowel Disease Management. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00161-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
268 Szirmay B, Tárnok A, Sarlós P, Szigeti N, Ludány A, Kustán P, Horváth-Szalai Z, Miseta A, Kőszegi T. Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease. Eur J Clin Invest 2019;49:e13054. [PMID: 30451301 DOI: 10.1111/eci.13054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
269 Alsahli S, Al Anazi A, Al Hatlani MM, Kashgari A, Al Sufiani F, Alfadhel M, Al Mutairi F. Severe Crohn's Disease Manifestations in a Child with Cystathionine β-Synthase Deficiency. ACG Case Rep J 2018;5:e93. [PMID: 30775396 DOI: 10.14309/crj.2018.93] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
270 Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG, Clark SK, Clifford S, Davies RJ, Davies MM, Douie WJP, Dunlop MG, Epstein JC, Evans MD, George BD, Guy RJ, Hargest R, Hawthorne AB, Hill J, Hughes GW, Limdi JK, Maxwell-Armstrong CA, O'Connell PR, Pinkney TD, Pipe J, Sagar PM, Singh B, Soop M, Terry H, Torkington J, Verjee A, Walsh CJ, Warusavitarne JH, Williams AB, Williams GL, Wilson RG; ACPGBI IBD Surgery Consensus Collaboration. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis 2018;20 Suppl 8:3-117. [PMID: 30508274 DOI: 10.1111/codi.14448] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
271 Zheng C, Huang Y, Ye Z, Wang Y, Tang Z, Lu J, Wu J, Zhou Y, Wang L, Huang Z, Yang H, Xue A. Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20). Inflamm Bowel Dis 2018;24:2613-20. [PMID: 29788367 DOI: 10.1093/ibd/izy165] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
272 El Mouzan MI, Winter HS, Assiri AA, Korolev KS, Al Sarkhy AA, Dowd SE, Al Mofarreh MA, Menon R. Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population. Gut Pathog 2018;10:49. [PMID: 30519287 DOI: 10.1186/s13099-018-0276-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
273 Kim D, Lee S, Kang SH, Park MS, Yoo SY, Jeon TY, Choi JS, Kim B, Choi JR, Cho SY, Chung DR, Choe YH, Kim YJ. A contact investigation after exposure to a child with disseminated tuberculosis mimicking inflammatory bowel disease. Korean J Pediatr 2018;61:366-70. [PMID: 30481995 DOI: 10.3345/kjp.2018.07206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
274 Kim J, Ye BD. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key? Intest Res 2019;17:24-35. [PMID: 30419636 DOI: 10.5217/ir.2018.00128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
275 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
276 Däbritz J, Gerner P, Enninger A, Claßen M, Radke M. Inflammatory Bowel Disease in Childhood and Adolescence. Dtsch Arztebl Int 2017;114:331-8. [PMID: 28597827 DOI: 10.3238/arztebl.2017.0331] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
277 Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study. Clin Epidemiol 2018;10:1613-26. [PMID: 30519110 DOI: 10.2147/CLEP.S178056] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
278 Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. J Can Assoc Gastroenterol 2019;2:S49-67. [PMID: 31294385 DOI: 10.1093/jcag/gwy056] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
279 Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J Can Assoc Gastroenterol 2019;2:S6-S16. [PMID: 31294381 DOI: 10.1093/jcag/gwy054] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 11.4] [Reference Citation Analysis]
280 Schwimmer MH, Sawh MC, Heskett KM, Goyal NP, Newton KP, Schwimmer JB. A Bibliometric Analysis of Clinical and Translational Research in Pediatric Gastroenterology From 1970 to 2017. J Pediatr Gastroenterol Nutr 2018;67:564-9. [PMID: 29901549 DOI: 10.1097/MPG.0000000000002056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
281 El Mouzan MI, Korolev KS, Al Mofarreh MA, Menon R, Winter HS, Al Sarkhy AA, Dowd SE, Al Barrag AM, Assiri AA. Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease. World J Gastroenterol 2018; 24(39): 4510-4516 [PMID: 30356965 DOI: 10.3748/wjg.v24.i39.4510] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
282 Collins A, Nolan E, Hurley M, D'Alton A, Hussey S. Anorexia Nervosa Complicating Pediatric Crohn Disease-Case Report and Literature Review. Front Pediatr 2018;6:283. [PMID: 30356737 DOI: 10.3389/fped.2018.00283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
283 Huang CC, Rescorla FJ, Landman MP. Clinical Outcomes After Ileal Pouch-Anal Anastomosis in Pediatric Patients. J Surg Res 2019;234:72-6. [PMID: 30527503 DOI: 10.1016/j.jss.2018.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
284 Strisciuglio C, Cenni S, Giugliano FP, Miele E, Cirillo G, Martinelli M, Vitale A, Tolone C, Staiano A, Miraglia Del Giudice E, Perrone L. The Role of Inflammation on Vitamin D Levels in a Cohort of Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:501-6. [PMID: 29877900 DOI: 10.1097/MPG.0000000000002049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
285 Guilcher K, Fournier N, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study. Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland. Eur J Gastroenterol Hepatol 2018;30:1159-67. [PMID: 29985208 DOI: 10.1097/MEG.0000000000001197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
286 Chanchlani N, Mortier K, Williams LJ, Muhammed R, Auth MKH, Cosgrove M, Fagbemi A, Fell J, Chong S, Zamvar V, Hyer W, Bisset WM, Morris MA, Rodrigues A, Mitton SG, Bunn S, Beattie RM, Willmott A, Wilson DC, Russell RK. Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort. J Pediatr Gastroenterol Nutr 2018;67:513-9. [PMID: 29697550 DOI: 10.1097/MPG.0000000000002011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
287 Timmer A, de Sordi D, Menke E, Peplies J, Claßen M, Koletzko S, Otto-Sobotka F. Modeling determinants of satisfaction with health care in youth with inflammatory bowel disease: a cross-sectional survey. Clin Epidemiol 2018;10:1289-305. [PMID: 30310323 DOI: 10.2147/CLEP.S165554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
288 Kuenzig ME, Bishay K, Leigh R, Kaplan GG, Benchimol EI; Crowdscreen SR Review Team. Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Clin Transl Gastroenterol 2018;9:188. [PMID: 30250122 DOI: 10.1038/s41424-018-0054-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
289 Sieczkowska-Golub J, Jarzebicka D, Oracz G, Kierkus J. Biosimilars in paediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(35): 4021-4027 [PMID: 30254406 DOI: 10.3748/wjg.v24.i35.4021] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
290 Kelly D, Kotliar M, Woo V, Jagannathan S, Whitt J, Moncivaiz J, Aronow BJ, Dubinsky MC, Hyams JS, Markowitz JF, Baldassano RN, Stephens MC, Walters TD, Kugathasan S, Haberman Y, Sundaram N, Rosen MJ, Helmrath M, Karns R, Barski A, Denson LA, Alenghat T. Microbiota-sensitive epigenetic signature predicts inflammation in Crohn's disease. JCI Insight 2018;3:122104. [PMID: 30232290 DOI: 10.1172/jci.insight.122104] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
291 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of Gut Microbiota Is Associated with Disease Remission in a Pediatric Crohn’s Disease Cohort.. [DOI: 10.1101/412890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 Tan Tanny SP, Yoo M, Hutson JM, Langer JC, King SK. Current surgical practice in pediatric ulcerative colitis: A systematic review. J Pediatr Surg 2019;54:1324-30. [PMID: 30241963 DOI: 10.1016/j.jpedsurg.2018.08.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
293 Aljomah G, Baker SS, Schmidt K, Alkhouri R, Kozielski R, Zhu L, Baker RD. Anemia in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:351-5. [PMID: 29668567 DOI: 10.1097/MPG.0000000000002002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
294 Maratová Ondřej Hradský Ph. Ondřej Souček KD, Šumník Z. Vitamin D and its supplementation in pediatric patients with inflammatory bowel disease. Pediatr pro Praxi 2018;19:190-194. [DOI: 10.36290/ped.2018.038] [Reference Citation Analysis]
295 Tajiri H, Motoya S, Kinjo F, Maemoto A, Matsumoto T, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T. Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan. PLoS One 2018;13:e0201956. [PMID: 30114224 DOI: 10.1371/journal.pone.0201956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
296 de Meij TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, Kneepkens CMF, Eck A, Benninga MA, Savelkoul PHM, van Bodegraven AA, Budding AE. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS One 2018;13:e0197649. [PMID: 30102706 DOI: 10.1371/journal.pone.0197649] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
297 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
298 Djurić Z, Šaranac L, Budić I, Pavlović V, Djordjević J. Therapeutic role of methotrexate in pediatric Crohn's disease. Bosn J Basic Med Sci 2018;18:211-6. [PMID: 29338679 DOI: 10.17305/bjbms.2018.2792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
299 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257-91. [PMID: 30044357 DOI: 10.1097/MPG.0000000000002035] [Cited by in Crossref: 188] [Cited by in F6Publishing: 157] [Article Influence: 37.6] [Reference Citation Analysis]
300 van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, Hurkmans PCWM, Stuyt RJL, Hendriks DM, van der Burg JAT, Utens EMWJ, Escher JC. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther 2018;48:358-69. [PMID: 29897134 DOI: 10.1111/apt.14832] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
301 Veereman G, Hauser B, De Greef E, Devreker T, Huysentruyt K, Lemmens R, Vandenplas Y. Reflections on treatment of IBD in children and adolescents. Immunopharmacol Immunotoxicol 2018;40:461-4. [PMID: 30040512 DOI: 10.1080/08923973.2018.1474922] [Reference Citation Analysis]
302 Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, Mayne J, Cheng K, Liao B, Li L, Singleton R, Mack D, Stintzi A, Figeys D. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun 2018;9:2873. [PMID: 30030445 DOI: 10.1038/s41467-018-05357-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 138] [Article Influence: 25.8] [Reference Citation Analysis]
303 Sýkora J, Pomahačová R, Kreslová M, Cvalínová D, Štych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol 2018; 24(25): 2741-2763 [PMID: 29991879 DOI: 10.3748/wjg.v24.i25.2741] [Cited by in CrossRef: 184] [Cited by in F6Publishing: 181] [Article Influence: 36.8] [Reference Citation Analysis]
304 Orscheln ES, Dillman JR, Towbin AJ, Denson LA, Trout AT. Penetrating Crohn disease: does it occur in the absence of stricturing disease? Abdom Radiol (NY) 2018;43:1583-9. [PMID: 29167943 DOI: 10.1007/s00261-017-1398-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
305 Ong C, Aw MM, Liwanag MJ, Quak SH, Phua KB. Rapid rise in the incidence and clinical characteristics of pediatric inflammatory bowel disease in a South-East Asian cohort in Singapore, 1994-2015. J Dig Dis 2018;19:395-403. [PMID: 29927059 DOI: 10.1111/1751-2980.12641] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
306 Talathi S, Mannion M, Colvin E, Beck A, Dabal R, Maclin J, Dimmitt R, Jester T. Aortitis With an Aneurysm at Initial Presentation of Crohn Disease. J Pediatr Gastroenterol Nutr 2018;67:e12-3. [PMID: 29927874 DOI: 10.1097/MPG.0000000000001945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
307 Lima Martins A, Volpato RA, Zago-Gomes MDP. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:87. [PMID: 29914399 DOI: 10.1186/s12876-018-0822-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 7.8] [Reference Citation Analysis]
308 Church PC, Hyams J, Ruemmele F, de Ridder L, Turner D, Griffiths AM. The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World. Can J Gastroenterol Hepatol 2018;2018:3190548. [PMID: 30009157 DOI: 10.1155/2018/3190548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
309 Auth MK, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM, Willmott A, Spray C, Vadamalayan B, Rodrigues A, Puntis J, Pigott AJ, Wilson DC, Mitton S, Furman M, Charlton C, Chong SKF, Russell RK; BSPGHAN IBD working group, BSPGHAN IBD site leads. Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom. Inflamm Bowel Dis 2018;24:1520-30. [PMID: 29668982 DOI: 10.1093/ibd/izy042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
310 Shaikhkhalil AK, Boyle B, Smith J, Dotson JL, Donegan A, Kim SC, Maltz RM, Crandall W. Using Quality Improvement to Increase Utilization of Enteral Therapy in Pediatric Crohn Disease: Results and Outcomes. J Pediatr Gastroenterol Nutr 2018;66:909-14. [PMID: 29315161 DOI: 10.1097/MPG.0000000000001879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 Suh JH, Degagné É, Gleghorn EE, Setty M, Rodriguez A, Park KT, Verstraete SG, Heyman MB, Patel AS, Irek M, Gildengorin GL, Hubbard NE, Borowsky AD, Saba JD. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study. Inflamm Bowel Dis 2018;24:1321-34. [PMID: 29788359 DOI: 10.1093/ibd/izy007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
312 Severs M, Spekhorst LM, Mangen MJ, Dijkstra G, Löwenberg M, Hoentjen F, van der Meulen-de Jong AE, Pierik M, Ponsioen CY, Bouma G, van der Woude JC, van der Valk ME, Romberg-Camps MJL, Clemens CHM, van de Meeberg P, Mahmmod N, Jansen J, Jharap B, Weersma RK, Oldenburg B, Festen EAM, Fidder HH. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies. Inflamm Bowel Dis 2018;24:1298-306. [PMID: 29688413 DOI: 10.1093/ibd/izy004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
313 de Meij T, de Groot E, Peeters C, de Boer N, Kneepkens C, Eck A, Benninga M, Savelkoul P, van Bodegraven A, Budding A. Variability of core microbiota in newly diagnosed treatment-naïve paediatric Inflammatory Bowel Disease patients.. [DOI: 10.1101/317263] [Reference Citation Analysis]
314 Bosch S, Struys EA, van Gaal N, Bakkali A, Jansen EW, Diederen K, Benninga MA, Mulder CJ, de Boer NKH, de Meij TGJ. Fecal Amino Acid Analysis Can Discriminate De Novo Treatment-Naïve Pediatric Inflammatory Bowel Disease From Controls. J Pediatr Gastroenterol Nutr 2018;66:773-8. [PMID: 29112087 DOI: 10.1097/MPG.0000000000001812] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
315 Strisciuglio C, Bellini G, Miele E, Martinelli M, Cenni S, Tortora C, Tolone C, Miraglia Del Giudice E, Rossi F. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease. J Clin Gastroenterol 2018;52:e37-43. [PMID: 27875353 DOI: 10.1097/MCG.0000000000000755] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
316 Lopez RN, Evans HM, Appleton L, Bishop J, Chin S, Mouat S, Gearry RB, Day AS. Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study. J Pediatr Gastroenterol Nutr 2018;66:e122-6. [PMID: 29077643 DOI: 10.1097/MPG.0000000000001806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
317 Deeke SA, Starr AE, Ning Z, Ahmadi S, Zhang X, Mayne J, Chiang CK, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis. Am J Gastroenterol 2018;113:713-24. [PMID: 29531307 DOI: 10.1038/s41395-018-0024-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
318 Rialon KL, Crowley E, Seemann NM, Fahy AS, Muise A, Langer JC. Long-term outcomes for children with very early-onset colitis: Implications for surgical management. Journal of Pediatric Surgery 2018;53:964-7. [DOI: 10.1016/j.jpedsurg.2018.02.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
319 Hansen T, Duerksen DR. Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease. Nutrients 2018;10:E537. [PMID: 29701656 DOI: 10.3390/nu10050537] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
320 Cozijnsen MA, Samsom JN, de Ridder L. Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability. Paediatr Drugs 2018;20:19-28. [PMID: 29079905 DOI: 10.1007/s40272-017-0266-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
321 Hong SJ, Cho SM, Choe BH, Jang HJ, Choi KH, Kang B, Kim JE, Hwang JH. Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study. J Korean Med Sci 2018;33:e132. [PMID: 29713253 DOI: 10.3346/jkms.2018.33.e132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
322 Terada A, Aoshima M, Tanizaki H, Nakazawa Y, Ogi T, Tokura Y, Moriwaki S. An adolescent case of xeroderma pigmentosum variant confirmed by the onset of sun exposure-related skin cancer during Crohn's disease treatment. J Cutan Immunol Allergy 2018;1:23-26. [DOI: 10.1002/cia2.12011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
323 Barfield E, Sockolow R, Hoffenberg E, Saeed S, Kim S, Siebold L, Picoraro J, Moses J, Dykes D, Grossman A, Wahbeh G, Park KT. Assuring Quality for Non-hospital-based Biologic Infusions in Pediatric Inflammatory Bowel Disease: A Clinical Report From the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:680-6. [PMID: 29324477 DOI: 10.1097/MPG.0000000000001890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
324 Narayanan SA, Metzger CE, Bloomfield SA, Zawieja DC. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease. FASEB J 2018;32:4848-61. [PMID: 29596023 DOI: 10.1096/fj.201800178R] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
325 Shaw KA, Cutler DJ, Okou D, Dodd A, Aronow BJ, Haberman Y, Stevens C, Walters TD, Griffiths A, Baldassano RN, Noe JD, Hyams JS, Crandall WV, Kirschner BS, Heyman MB, Snapper S, Guthery S, Dubinsky MC, Shapiro JM, Otley AR, Daly M, Denson LA, Kugathasan S, Zwick ME. Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort. Genes Immun 2019;20:131-42. [PMID: 29593342 DOI: 10.1038/s41435-018-0015-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
326 Shcherbakova OV, Razumovskiy AY. INDICATIONS FOR THE SURGICAL TREATMENT IN CHILDREN AND ADOLESCENTS WITH COMPLICATED CROWN DISEASE (REVIEW OF LITERATURE). Det hir 2018;22:35-41. [DOI: 10.18821/1560-9510-2018-22-1-35-41] [Reference Citation Analysis]
327 Akintimehin AO, O'Neill RS, Ring C, Raftery T, Hussey S. Outcomes of a National Cohort of Children with Acute Severe Ulcerative Colitis. Front Pediatr 2018;6:48. [PMID: 29568735 DOI: 10.3389/fped.2018.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
328 Fang YH, Luo YY, Yu JD, Lou JG, Chen J. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. World J Gastroenterol 2018; 24(9): 1035-1045 [PMID: 29531467 DOI: 10.3748/wjg.v24.i9.1035] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
329 von Allmen D. Pediatric Crohn's Disease. Clin Colon Rectal Surg 2018;31:80-8. [PMID: 29487490 DOI: 10.1055/s-0037-1609022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
330 Shaikhkhalil AK, Crandall W. Enteral Nutrition for Pediatric Crohn's Disease: An Underutilized Therapy. Nutr Clin Pract 2018;33:493-509. [PMID: 29446858 DOI: 10.1002/ncp.10011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
331 Gumidyala AP, Greenley RN, Plevinsky JM, Poulopoulos N, Cabrera J, Lerner D, Noe JD, Walkiewicz D, Werlin S, Kahn SA. Moving On: Transition Readiness in Adolescents and Young Adults With IBD. Inflamm Bowel Dis 2018;24:482-9. [PMID: 29462383 DOI: 10.1093/ibd/izx051] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
332 Barnes EL, Kappelman MD. Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment. Am J Gastroenterol 2018;113:273-5. [PMID: 29467539 DOI: 10.1038/ajg.2017.431] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
333 deBruyn JC, Jacobson K, El-Matary W, Carroll M, Wine E, Wrobel I, Van Woudenberg M, Huynh HQ. Long-term Outcomes of Infliximab Use for Pediatric Crohn Disease: A Canadian Multicenter Clinical Practice Experience. J Pediatr Gastroenterol Nutr 2018;66:268-73. [PMID: 28657923 DOI: 10.1097/MPG.0000000000001672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
334 Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response. J Pediatr Gastroenterol Nutr 2018;66:274-80. [PMID: 29356768 DOI: 10.1097/MPG.0000000000001679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
335 Howell KJ, Kraiczy J, Nayak KM, Gasparetto M, Ross A, Lee C, Mak TN, Koo BK, Kumar N, Lawley T, Sinha A, Rosenstiel P, Heuschkel R, Stegle O, Zilbauer M. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome. Gastroenterology 2018;154:585-98. [PMID: 29031501 DOI: 10.1053/j.gastro.2017.10.007] [Cited by in Crossref: 152] [Cited by in F6Publishing: 153] [Article Influence: 30.4] [Reference Citation Analysis]
336 Chien KA, Hammad HT, Gerber L, Sheth S, Sockolow R, Kucine N. Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;66:286-8. [PMID: 28742719 DOI: 10.1097/MPG.0000000000001690] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
337 Lopez RN, Appleton L, Gearry RB, Day AS. Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015. J Pediatr Gastroenterol Nutr 2018;66:e45-50. [PMID: 28727653 DOI: 10.1097/MPG.0000000000001688] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
338 Uggla C, Lindh V, Lind T, Lindkvist M. IMPACT-III is a valid and reliable questionnaire for assessing health-related quality of life in Swedish children with inflammatory bowel disease. Acta Paediatr 2018;107:347-53. [PMID: 29032599 DOI: 10.1111/apa.14119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
339 Nordenvall C, Rosvall O, Bottai M, Everhov ÅH, Malmborg P, Smedby KE, Ekbom A, Askling J, Ludvigsson JF, Myrelid P, Olén O. Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014. J Crohns Colitis 2018;12:157-66. [PMID: 29029152 DOI: 10.1093/ecco-jcc/jjx132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
340 Weimers P, Munkholm P. The Natural History of IBD: Lessons Learned. Curr Treat Options Gastroenterol 2018;16:101-11. [PMID: 29359275 DOI: 10.1007/s11938-018-0173-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
341 Alsahli S, Al Anazi A, Al Hatlani MM, Kashgari A, Al Sufiani F, Alfadhel M, Al Mutairi F. Severe Crohnʼs Disease Manifestations in a Child with Cystathionine β-Synthase Deficiency. ACG Case Reports Journal 2018;5:e931-4. [DOI: 10.14309/02075970-201805120-00009] [Reference Citation Analysis]
342 Alcalá R, González-enseñat MA, Vicente A. Manifestaciones mucocutáneas de la enfermedad inflamatoria intestinal en la población pediátrica. Piel 2018;33:21-32. [DOI: 10.1016/j.piel.2017.02.005] [Reference Citation Analysis]
343 Patel S, Strople J. Biologic Therapy in Pediatric Inflammatory Bowel Disease. Treatment of Inflammatory Bowel Disease with Biologics 2018. [DOI: 10.1007/978-3-319-60276-9_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
344 Lang T, Ure B, Melter M. Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen. Pädiatrische Endokrinologie und Diabetologie 2018. [DOI: 10.1007/978-3-662-53390-1_57-1] [Reference Citation Analysis]
345 Alsahli S, Al Anazi A, Al Hatlani MM, Kashgari A, Al Sufiani F, Alfadhel M, Al Mutairi F. Severe Crohnʼs Disease Manifestations in a Child with Cystathionine β-Synthase Deficiency. ACG Case Reports Journal 2018;5:e93. [DOI: 10.14309/02075970-201805000-00093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
346 Shcherbakova OV, Poddoubnyi IV, Kozlov MY. COMPLICATED Crohn's disease IN ADOLESCENTS: FEATURES, INDICATIONS FOR SURGICAL TREATMENT, DIFFICULTY OF TRANSITION of care (review article). Koloproktologiâ 2017. [DOI: 10.33878/2073-7556-2017-0-4-88-98] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
347 Cho JM, Yang HR. Hair Mineral and Trace Element Contents as Reliable Markers of Nutritional Status Compared to Serum Levels of These Elements in Children Newly Diagnosed with Inflammatory Bowel Disease. Biol Trace Elem Res 2018;185:20-9. [PMID: 29282618 DOI: 10.1007/s12011-017-1225-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
348 de Laffolie J, Laass MW, Scholz D, Zimmer KP, Buderus S; CEDATA-GPGE Study Group . Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®. Gastroenterol Res Pract 2017;2017:8424628. [PMID: 29358946 DOI: 10.1155/2017/8424628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
349 Kahn SA, Lin CW, Ozbay B, Wang A, Chao J, Skup M. Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States. Inflamm Bowel Dis 2017;23:2089-96. [PMID: 28961604 DOI: 10.1097/MIB.0000000000001268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
350 Wilson DC, Russell RK. Overview of paediatric IBD. Seminars in Pediatric Surgery 2017;26:344-8. [DOI: 10.1053/j.sempedsurg.2017.10.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
351 Nasiri S, Kuenzig ME, Benchimol EI. Long-term outcomes of pediatric inflammatory bowel disease. Seminars in Pediatric Surgery 2017;26:398-404. [DOI: 10.1053/j.sempedsurg.2017.10.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
352 Wang L, Hong Y, Wu J, Leung YK, Huang Y. Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis. World J Gastroenterol 2017; 23(43): 7727-7734 [PMID: 29209113 DOI: 10.3748/wjg.v23.i43.7727] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
353 Timmer A, Stark R, Peplies J, Classen M, Laass MW, Koletzko S. Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: a survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset. Eur J Gastroenterol Hepatol 2017;29:1276-83. [PMID: 28877085 DOI: 10.1097/MEG.0000000000000956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
354 Fahy AS, Potter DD, Ravi A, Reissis Y, Faubion WA, Tung J. Colectomy in refractory Crohn's colitis improves nutrition and reduces steroid use. Journal of Pediatric Surgery 2017;52:1769-75. [DOI: 10.1016/j.jpedsurg.2017.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
355 Sjöberg F, Barkman C, Nookaew I, Östman S, Adlerberth I, Saalman R, Wold AE. Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis. PLoS One 2017;12:e0186178. [PMID: 29049404 DOI: 10.1371/journal.pone.0186178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
356 Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769-2778. [PMID: 29050646 DOI: 10.1016/s0140-6736(17)32448-0] [Cited by in Crossref: 2264] [Cited by in F6Publishing: 2430] [Article Influence: 377.3] [Reference Citation Analysis]
357 Siow VS, Bhatt R, Mollen KP. Management of acute severe ulcerative colitis in children. Semin Pediatr Surg. 2017;26:367-372. [PMID: 29126505 DOI: 10.1053/j.sempedsurg.2017.10.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
358 Dipasquale V, Romano C. Vaccination strategies in pediatric inflammatory bowel disease. Vaccine 2017;35:6070-5. [DOI: 10.1016/j.vaccine.2017.09.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
359 Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. The Lancet Child & Adolescent Health 2017;1:147-58. [DOI: 10.1016/s2352-4642(17)30017-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
360 Ishige T, Tomomasa T, Hatori R, Tatsuki M, Igarashi Y, Sekine K, Arakawa H. Temporal Trend of Pediatric Inflammatory Bowel Disease: Analysis of National Registry Data 2004 to 2013 in Japan. J Pediatr Gastroenterol Nutr 2017;65:e80-2. [PMID: 28207475 DOI: 10.1097/MPG.0000000000001547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
361 Olén O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014. BMJ 2017;358:j3951. [PMID: 28931512 DOI: 10.1136/bmj.j3951] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 14.3] [Reference Citation Analysis]
362 Varni JW, Shulman RJ, Self MM, Saeed SA, Zacur GM, Patel AS, Nurko S, Neigut DA, Franciosi JP, Saps M, Denham JM, Dark CV, Bendo CB, Pohl JF; Pediatric Quality of Life Inventory™ Gastrointestinal Symptoms Module Testing Study Consortium. Perceived medication adherence barriers mediating effects between gastrointestinal symptoms and health-related quality of life in pediatric inflammatory bowel disease. Qual Life Res 2018;27:195-204. [PMID: 28887749 DOI: 10.1007/s11136-017-1702-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
363 Hommel KA, McGrady ME, Peugh J, Zacur G, Loreaux K, Saeed S, Williams E, Denson LA. Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs. Inflamm Bowel Dis 2017;23:1577-83. [PMID: 28617754 DOI: 10.1097/MIB.0000000000001165] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
364 Bollegala N, Benchimol EI, Griffiths AM, Kovacs A, Steinhart AH, Zhao X, Nguyen GC. Characterizing the Posttransfer Period Among Patients with Pediatric Onset IBD: The Impact of Academic Versus Community Adult Care on Emergent Health Resource Utilization. Inflamm Bowel Dis 2017;23:1483-91. [PMID: 28816756 DOI: 10.1097/MIB.0000000000001200] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
365 Wauters L, Smets F, De Greef E, Bontems P, Hoffman I, Hauser B, Alliet P, Arts W, Peeters H, Van Biervliet S, Paquot I, Van de Vijver E, De Vos M, Bossuyt P, Rahier JF, Dewit O, Moreels T, Franchimont D, Muls V, Fontaine F, Louis E, Coche JC, Baert F, Paul J, Vermeire S, Veereman G. Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO). Inflamm Bowel Dis 2017;23:1584-91. [PMID: 28696956 DOI: 10.1097/MIB.0000000000001193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
366 Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN. Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol 2017;112:1412-22. [PMID: 28741616 DOI: 10.1038/ajg.2017.208] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 10.5] [Reference Citation Analysis]
367 Monasta L, Pierobon C, Princivalle A, Martelossi S, Marcuzzi A, Pasini F, Perbellini L. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One 2017;12:e0184118. [PMID: 28859138 DOI: 10.1371/journal.pone.0184118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
368 Day AS, Leach ST, Lemberg DA. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease. Expert Rev Mol Diagn. 2017;17:835-843. [PMID: 28770636 DOI: 10.1080/14737159.2017.1364160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
369 Ricciuto A, Fish JR, Tomalty DE, Carman N, Crowley E, Popalis C, Muise A, Walters TD, Griffiths AM, Church PC. Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height. Arch Dis Child. 2018;103:319-326. [PMID: 28794097 DOI: 10.1136/archdischild-2017-313060] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
370 Fu N, Jacobson K, Round A, Evans K, Qian H, Bressler B. Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(29): 5405-5411 [PMID: 28839441 DOI: 10.3748/wjg.v23.i29.5405] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
371 Strohl M, Zhang X, Lévesque D, Bessissow T. Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses. World J Gastrointest Pharmacol Ther 2017; 8(3): 186-192 [PMID: 28828197 DOI: 10.4292/wjgpt.v8.i3.186] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
372 Rinawi F, Assa A, Bashir H, Peleg S, Shamir R. Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel. Dig Dis Sci 2017;62:2095-101. [PMID: 28547648 DOI: 10.1007/s10620-017-4623-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
373 Lopez RN, Evans HM, Appleton L, Bishop J, Chin S, Mouat S, Gearry RB, Day AS. Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study. Inflamm Bowel Dis 2017;23:1418-24. [PMID: 28570430 DOI: 10.1097/MIB.0000000000001138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
374 Lin Z, Wang Z, Hegarty JP, Lin TR, Wang Y, Deiling S, Wu R, Thomas NJ, Floros J. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease. World J Gastroenterol 2017; 23(27): 4897-4909 [PMID: 28785144 DOI: 10.3748/wjg.v23.i27.4897] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
375 de Silva PSA, Fishman LN. The Transition of the Gastrointestinal Patient from Pediatric to Adult Care. Pediatr Clin North Am 2017;64:707-20. [PMID: 28502447 DOI: 10.1016/j.pcl.2017.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
376 Barber J, Maclachlan J, Planche K, Furman M, Crespi D, Bab N, Beal I. There is good agreement between MR enterography and bowel ultrasound with regards to disease location and activity in paediatric inflammatory bowel disease. Clinical Radiology 2017;72:590-7. [DOI: 10.1016/j.crad.2017.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
377 Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM, Mack DR, Jacobson K, Mojaverian N, Tanyingoh D, Cui Y, Nugent ZJ, Coulombe J, Targownik LE, Jones JL, Leddin D, Murthy SK, Kaplan GG. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases. Am J Gastroenterol 2017;112:1120-34. [PMID: 28417994 DOI: 10.1038/ajg.2017.97] [Cited by in Crossref: 190] [Cited by in F6Publishing: 187] [Article Influence: 31.7] [Reference Citation Analysis]
378 Schwarz J, Sýkora J, Cvalínová D, Pomahačová R, Klečková J, Kryl M, Včelák P. Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015. World J Gastroenterol 2017; 23(22): 4090-4101 [PMID: 28652662 DOI: 10.3748/wjg.v23.i22.4090] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
379 Hyams JS, Dubinsky MC, Baldassano RN, Colletti RB, Cucchiara S, Escher J, Faubion W, Fell J, Gold BD, Griffiths A, Koletzko S, Kugathasan S, Markowitz J, Ruemmele FM, Veereman G, Winter H, Masel N, Shin CR, Tang KL, Thayu M. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology 2017;152:1901-1914.e3. [PMID: 28193515 DOI: 10.1053/j.gastro.2017.02.004] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 22.7] [Reference Citation Analysis]
380 Whitfield E, Adler J, Gebremariam A, Davis M. Insurance Among Young Adults With Inflammatory Bowel Disease: Changes Under the Affordable Care Act Dependent Provision. J Pediatr Gastroenterol Nutr 2017;64:962-5. [PMID: 27513697 DOI: 10.1097/MPG.0000000000001378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
381 Coughlan A, Wylde R, Lafferty L, Quinn S, Broderick A, Bourke B, Hussey S; DOCHAS Study. A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease. Aliment Pharmacol Ther 2017;45:1534-41. [PMID: 28449214 DOI: 10.1111/apt.14070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
382 Brooks AJ, Smith PJ, Cohen R, Collins P, Douds A, Forbes V, Gaya DR, Johnston BT, McKiernan PJ, Murray CD, Sebastian S, Smith M, Whitley L, Williams L, Russell RK, McCartney SA, Lindsay JO. UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care. Gut 2017;66:988-1000. [PMID: 28228488 DOI: 10.1136/gutjnl-2016-313000] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
383 Walters TD, Faubion WA, Griffiths AM, Baldassano RN, Escher J, Ruemmele FM, Hyams JS, Lazar A, Eichner S, Huang B, Li Y, Thakkar RB. Growth Improvement with Adalimumab Treatment in Children with Moderately to Severely Active Crohn's Disease. Inflamm Bowel Dis 2017;23:967-75. [PMID: 28301428 DOI: 10.1097/MIB.0000000000001075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
384 Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017;357:j2083. [PMID: 28566467 DOI: 10.1136/bmj.j2083] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
385 El-Matary W, Benchimol EI, Mack D, Huynh HQ, Critch J, Otley A, Deslandres C, Jacobson K, deBruyn J, Carroll MW, Wine E, Van Limbergen J, Sherlock M, Bax K, Lawrence S, Seidman E, Issenman R, Walters TD, Church P, Griffiths AM. Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. Foundation. Can J Gastroenterol Hepatol 2017;2017:3676474. [PMID: 28593172 DOI: 10.1155/2017/3676474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
386 Javalkar K, Rak E, Phillips A, Haberman C, Ferris M, Van Tilburg M. Predictors of Caregiver Burden among Mothers of Children with Chronic Conditions. Children (Basel) 2017;4:E39. [PMID: 28509853 DOI: 10.3390/children4050039] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
387 Gale HI, Sharatz SM, Taphey M, Bradley WF, Nimkin K, Gee MS. Comparison of CT enterography and MR enterography imaging features of active Crohn disease in children and adolescents. Pediatr Radiol 2017;47:1321-8. [DOI: 10.1007/s00247-017-3876-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
388 Adler J, Dong S, Eder SJ, Dombkowski KJ; ImproveCareNow Pediatric IBD Learning Health System. Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative. J Pediatr Gastroenterol Nutr 2017;64:e117-24. [PMID: 27801750 DOI: 10.1097/MPG.0000000000001447] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
389 Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE, Peyrin-Biroulet L, Savoye G, Turck D, Gower-Rousseau C; EPIMAD Group. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis 2017;11:519-26. [PMID: 28453757 DOI: 10.1093/ecco-jcc/jjw194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
390 Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, Neigut DA, Saps M, Zacur GM, Dark CV, Bendo CB, Pohl JF. Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23:704-11. [PMID: 28394807 DOI: 10.1097/MIB.0000000000001077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
391 Martino JV, Van Limbergen J, Cahill LE. The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation. Front Pediatr 2017;5:96. [PMID: 28507982 DOI: 10.3389/fped.2017.00096] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 9.8] [Reference Citation Analysis]
392 Cohen SA, Aloi M, Arumugam R, Baker R, Bax K, Kierkuś J, Koletzko S, Lionetti P, Persson T, Eklund S. Enteric-coated budesonide for the induction and maintenance of remission of Crohn's disease in children. Curr Med Res Opin 2017;33:1261-8. [PMID: 28420280 DOI: 10.1080/03007995.2017.1313213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
393 Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy. Scand J Gastroenterol 2017;52:414-9. [PMID: 27887202 DOI: 10.1080/00365521.2016.1259653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
394 Hammer T, Lophaven SN, Nielsen KR, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther 2017;45:1107-14. [PMID: 28176348 DOI: 10.1111/apt.13975] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
395 Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, Wang Z, Wang Y, Wu B, Wang H, Zeng H, Yu Z, Zheng C, Wang Y, Huang Y. Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis 2017;23:578-90. [PMID: 28267044 DOI: 10.1097/MIB.0000000000001058] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
396 Lophaven SN, Lynge E, Burisch J. The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study. Aliment Pharmacol Ther 2017;45:961-72. [PMID: 28229470 DOI: 10.1111/apt.13971] [Cited by in Crossref: 85] [Cited by in F6Publishing: 62] [Article Influence: 14.2] [Reference Citation Analysis]
397 Szymanska E, Dadalski M, Grajkowska W, Szymanska S, Pronicki M, Kierkus J. Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn's disease. Prz Gastroenterol 2017;12:44-8. [PMID: 28337236 DOI: 10.5114/pg.2016.64746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
398 Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V. Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis 2017;11:321-34. [PMID: 27609529 DOI: 10.1093/ecco-jcc/jjw158] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 8.7] [Reference Citation Analysis]
399 Metzger CE, Narayanan A, Zawieja DC, Bloomfield SA. Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover: IBD IN RODENT MODEL ALTERS OSTEOCYTE PROTEIN CONTROLLING BONE TURNOVER. J Bone Miner Res 2017;32:802-13. [DOI: 10.1002/jbmr.3027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
400 Zemel BS. Influence of complex childhood diseases on variation in growth and skeletal development: ZEMEL. Am J Hum Biol 2017;29:e22985. [DOI: 10.1002/ajhb.22985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
401 Clowry J, Sheridan J, Healy R, Deady S, Keegan D, Byrne K, Cullen G, Mulcahy H, Comber H, Parnell A, Doherty G, Lally A. Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study. J Eur Acad Dermatol Venereol 2017;31:978-85. [DOI: 10.1111/jdv.14105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
402 Virta LJ, Saarinen MM, Kolho KL. Inflammatory Bowel Disease Incidence is on the Continuous Rise Among All Paediatric Patients Except for the Very Young: A Nationwide Registry-based Study on 28-Year Follow-up. J Crohns Colitis 2017;11:150-6. [PMID: 27555642 DOI: 10.1093/ecco-jcc/jjw148] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
403 Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C. The natural history of Crohn's disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol 2017;29:125-34. [PMID: 27748673 DOI: 10.1097/MEG.0000000000000761] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
404 Corica D, Romano C. Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review. J Clin Gastroenterol 2017;51:100-10. [PMID: 27636407 DOI: 10.1097/MCG.0000000000000696] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
405 Merras-Salmio L, Kolho KL. Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;64:272-8. [PMID: 27149256 DOI: 10.1097/MPG.0000000000001258] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
406 Ludvigsson JF, Büsch K, Olén O, Askling J, Smedby KE, Ekbom A, Lindberg E, Neovius M. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study. BMC Gastroenterol 2017;17:23. [PMID: 28143594 DOI: 10.1186/s12876-017-0578-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
407 Schwerd T, Koletzko S. Chronisch entzündliche Darmerkrankungen. Monatsschr Kinderheilkd 2017;165:257-70. [DOI: 10.1007/s00112-017-0243-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
408 Budd GR, Aitchison A, Day AS, Keenan JI. The effect of polymeric formula on enterocyte differentiation. Innate Immun 2017;23:240-8. [DOI: 10.1177/1753425916689333] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
409 Kammermeier J, Dziubak R, Pescarin M, Drury S, Godwin H, Reeve K, Chadokufa S, Huggett B, Sider S, James C, Acton N, Cernat E, Gasparetto M, Noble-Jamieson G, Kiparissi F, Elawad M, Beales PL, Sebire NJ, Gilmour K, Uhlig HH, Bacchelli C, Shah N. Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years. J Crohns Colitis 2017;11:60-9. [PMID: 27302973 DOI: 10.1093/ecco-jcc/jjw118] [Cited by in Crossref: 91] [Cited by in F6Publishing: 106] [Article Influence: 15.2] [Reference Citation Analysis]
410 Saeed SA, Kugathasan S. Epidemiology of Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
411 Chae A, Aitchison A, Day AS, Keenan JI. Bovine colostrum demonstrates anti-inflammatory and antibacterial activity in in vitro models of intestinal inflammation and infection. Journal of Functional Foods 2017;28:293-8. [DOI: 10.1016/j.jff.2016.11.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
412 Gumidyala AP, Plevinsky JM, Poulopoulos N, Kahn SA, Walkiewicz D, Greenley RN. What Teens Do Not Know Can Hurt Them: An Assessment of Disease Knowledge in Adolescents and Young Adults with IBD. Inflamm Bowel Dis 2017;23:89-96. [PMID: 28002128 DOI: 10.1097/MIB.0000000000000974] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
413 Di Nardo G, Pession A, Bertelli L, Isoldi S, Cozzali R, Maffi M, Lima M. Inflammatory Bowel Disease. Pediatric Digestive Surgery 2017. [DOI: 10.1007/978-3-319-40525-4_23] [Reference Citation Analysis]
414 Stein R, Baldassano RN. Dietary Therapies for Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
415 Karolewska-Bochenek K, Grzesiowski P, Banaszkiewicz A, Gawronska A, Kotowska M, Dziekiewicz M, Albrecht P, Radzikowski A, Lazowska-Przeorek I. A Two-Week Fecal Microbiota Transplantation Course in Pediatric Patients with Inflammatory Bowel Disease. Adv Exp Med Biol 2018;1047:81-7. [PMID: 29151253 DOI: 10.1007/5584_2017_123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
416 Cucchiara S, Aloi M. Clinical Trials (Clinical Perspective). Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_47] [Reference Citation Analysis]
417 Lee YA, Chun P, Hwang EH, Mun SW, Lee YJ, Park JH. Clinical Features and Extraintestinal Manifestations of Crohn Disease in Children. Pediatr Gastroenterol Hepatol Nutr 2016;19:236-42. [PMID: 28090468 DOI: 10.5223/pghn.2016.19.4.236] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
418 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
419 Cozijnsen MA, van Pieterson M, Samsom JN, Escher JC, de Ridder L. Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial. BMJ Open Gastroenterol 2016;3:e000123. [PMID: 28090335 DOI: 10.1136/bmjgast-2016-000123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
420 Altowati MA, Jones AP, Hickey H, Williamson PR, Barakat FM, Plaatjies NC, Hardwick B, Russell RK, Jaki T, Ahmed SF, Sanderson IR. Assessing the feasibility of injectable growth-promoting therapy in Crohn's disease. Pilot Feasibility Stud 2016;2:71. [PMID: 27965886 DOI: 10.1186/s40814-016-0112-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
421 Varni JW, Shulman RJ, Self MM, Saeed SA, Patel AS, Nurko S, Neigut DA, Saps M, Franciosi JP, Denham JM, Zacur GM, Dark CV, Bendo CB, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. Gastrointestinal Symptoms Predictors of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2016;63:e186-92. [PMID: 27749610 DOI: 10.1097/MPG.0000000000001428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
422 Kapoor A, Bhatia V, Sibal A. Pediatric inflammatory bowel disease. Indian Pediatr 2016;53:993-1002. [DOI: 10.1007/s13312-016-0975-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
423 Ananthakrishnan AN, Shi HY, Tang W, Law CC, Sung JJ, Chan FK, Ng SC. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. J Crohns Colitis 2016;10:1224-36. [PMID: 26928965 DOI: 10.1093/ecco-jcc/jjw054] [Cited by in Crossref: 90] [Cited by in F6Publishing: 88] [Article Influence: 12.9] [Reference Citation Analysis]
424 Kornienko EA, Krupina AN, Gabrusskaya TV, Kalinina NM. Inflammatory bowel disease with a very early onset. Alʹm klin med 2016;44:719-733. [DOI: 10.18786/2072-0505-2016-44-6-719-733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
425 Giannakopoulos G, Chouliaras G, Margoni D, Korlou S, Hantzara V, Panayotou I, Roma E, Liakopoulou M, Anagnostopoulos DC. Stressful life events and psychosocial correlates of pediatric inflammatory bowel disease activity. World J Psychiatr 2016; 6(3): 322-328 [PMID: 27679771 DOI: 10.5498/wjp.v6.i3.322] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
426 Reigada LC, Satpute A, Hoogendoorn CJ, Cohen BH, Lai J, Bao R, Dubinsky MC, Benkov KJ. Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use. Inflamm Bowel Dis 2016;22:2127-33. [PMID: 27482980 DOI: 10.1097/MIB.0000000000000864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
427 Larsen MD, Baldal ME, Nielsen RG, Nielsen J, Lund K, Nørgård BM. The incidence of Crohn's disease and ulcerative colitis since 1995 in Danish children and adolescents <17 years - based on nationwide registry data. Scand J Gastroenterol 2016;51:1100-5. [PMID: 27160395 DOI: 10.3109/00365521.2016.1172340] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
428 Manhart A, Hellmann S, Hamelmann E, Schlarb AA. The association of sleep with inflammatory bowel disease in children and adolescents. Somnologie 2016;20:212-218. [DOI: 10.1007/s11818-016-0067-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
429 Yammine S, Nyilas S, Casaulta C, Schibli S, Latzin P, Sokollik C. Function and Ventilation of Large and Small Airways in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1915-22. [PMID: 27120569 DOI: 10.1097/MIB.0000000000000779] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
430 De Greef E, Hoffman I, Smets F, Van Biervliet S, Bontems P, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, De Vos M, Baert F, Bossuyt P, Rahier JF, Franchimont D, Vermeire S, Fontaine F, Louis E, Coche JC, Veereman G; IBD working group of BESPGHAN, BIRD. Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up. J Pediatr Gastroenterol Nutr 2016;63:253-8. [PMID: 26835906 DOI: 10.1097/MPG.0000000000001132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
431 Al-Hussaini A, El Mouzan M, Hasosah M, Al-Mehaidib A, ALSaleem K, Saadah OI, Al-Edreesi M. Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study. Inflamm Bowel Dis 2016;22:1961-70. [PMID: 27104817 DOI: 10.1097/MIB.0000000000000796] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
432 Ehman EC, Phelps AS, Ohliger MA, Rhee SJ, MacKenzie JD, Courtier JL. Detection of bowel inflammation with fused DWI/T2 images versus contrast-enhanced images in pediatric MR enterography with histopathologic correlation. Clin Imaging 2016;40:1135-9. [PMID: 27497037 DOI: 10.1016/j.clinimag.2016.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
433 Knieling F, Waldner MJ. Light and sound - emerging imaging techniques for inflammatory bowel disease. World J Gastroenterol 2016; 22(25): 5642-5654 [PMID: 27433080 DOI: 10.3748/wjg.v22.i25.5642] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
434 Trindade E. Pediatric Crohn's Disease and Surgery: Another Tool for the Treatment of a Complex Disease. GE Port J Gastroenterol 2016;23:181-2. [PMID: 28868457 DOI: 10.1016/j.jpge.2016.05.002] [Reference Citation Analysis]
435 Brooks AJ, Rowse G, Ryder A, Peach EJ, Corfe BM, Lobo AJ. Systematic review: psychological morbidity in young people with inflammatory bowel disease - risk factors and impacts. Aliment Pharmacol Ther 2016;44:3-15. [PMID: 27145394 DOI: 10.1111/apt.13645] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 7.9] [Reference Citation Analysis]
436 Lehtinen P, Pasanen K, Kolho KL, Auvinen A. Incidence of Pediatric Inflammatory Bowel Disease in Finland: An Environmental Study. J Pediatr Gastroenterol Nutr 2016;63:65-70. [PMID: 26636498 DOI: 10.1097/MPG.0000000000001050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
437 Kolho KL, Ainamo A. Progress in the treatment and outcome of pediatric inflammatory bowel disease patients. Expert Rev Clin Immunol. 2016;12:1337-1345. [PMID: 27322874 DOI: 10.1080/1744666x.2016.1201422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
438 Cole R, Ashok D, Razack A, Azaz A, Sebastian S. Evaluation of Outcomes in Adolescent Inflammatory Bowel Disease Patients Following Transfer From Pediatric to Adult Health Care Services: Case for Transition. J Adolesc Health 2015;57:212-7. [PMID: 26206442 DOI: 10.1016/j.jadohealth.2015.04.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 10.9] [Reference Citation Analysis]
439 Palle SK, Prasad M, Kugathasan S. Approach to a Child with Colitis. Indian J Pediatr 2016;83:1444-51. [PMID: 27080713 DOI: 10.1007/s12098-016-2091-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
440 Virta LJ, Kautiainen H, Kolho KL. Symptoms suggestive of cow's milk allergy in infancy and pediatric inflammatory bowel disease. Pediatr Allergy Immunol 2016;27:361-7. [PMID: 26887931 DOI: 10.1111/pai.12551] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
441 Cullen M. The role of endoscopy in the diagnosis and management of Crohn's disease in children. Gastrointestinal Nursing 2016;14:15-16. [DOI: 10.12968/gasn.2016.14.3.15] [Reference Citation Analysis]
442 Reed-Knight B, Lee JL, Greenley RN, Lewis JD, Blount RL. Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:963-7. [PMID: 26818418 DOI: 10.1097/MIB.0000000000000686] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
443 Wikholm E, Malmborg P, Forssberg M, Hederos CA, Wikström S. Iron Deficiency Is Common During Remission in Children With Inflammatory Bowel Disease. Glob Pediatr Health 2016;3:2333794X16633672. [PMID: 27336004 DOI: 10.1177/2333794X16633672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
444 Mueller R, Ziade F, Pittet V, Fournier N, Ezri J, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study. Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way? J Crohns Colitis 2016;10:269-76. [PMID: 26519462 DOI: 10.1093/ecco-jcc/jjv199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
445 Huntington JT, Boomer LA, Pepper VK, Diefenbach KA, Dotson JL, Nwomeh BC. Minimally Invasive Ileal Pouch-Anal Anastomosis with Rectal Eversion Allows for Equivalent Outcomes in Continence in Pediatric Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:222-5. [DOI: 10.1089/lap.2015.0429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
446 Haas K, Rubesova E, Bass D. Role of imaging in the evaluation of inflammatory bowel disease: How much is too much? World J Radiol 2016; 8(2): 124-131 [PMID: 26981221 DOI: 10.4329/wjr.v8.i2.124] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
447 Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015;169:1053-1060. [PMID: 26414706 DOI: 10.1001/jamapediatrics.2015.1982] [Cited by in Crossref: 286] [Cited by in F6Publishing: 298] [Article Influence: 40.9] [Reference Citation Analysis]
448 Szymanska E, Dadalski M, Szymanska S, Grajkowska W, Pronicki M, Kierkus J. The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease. Prz Gastroenterol 2016;11:176-80. [PMID: 27713779 DOI: 10.5114/pg.2016.57753] [Reference Citation Analysis]
449 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(1): 112-125 [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
450 Fumery M, Duricova D, Gower-Rousseau C, Annese V, Peyrin-Biroulet L, Lakatos PL. Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther 2016;43:346-55. [PMID: 26582737 DOI: 10.1111/apt.13478] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
451 Carroll MW, Hamilton Z, Gill H, Simkin J, Smyth M, Espinosa V, Bressler B, Jacobson K. Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype. Inflamm Bowel Dis 2016;22:387-96. [PMID: 26752467 DOI: 10.1097/MIB.0000000000000651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
452 Fofanova TY, Petrosino JF, Kellermayer R. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;62:208-19. [PMID: 26308318 DOI: 10.1097/MPG.0000000000000950] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
453 Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FD, Tjønneland A, Olsen A, Dahm CC, Key T, Luben R, Khaw KT, Riboli E, Grip O, Lindgren S, Hallmans G, Karling P, Clavel-Chapelon F, Bergman MM, Boeing H, Kaaks R, Katzke VA, Palli D, Masala G, Jantchou P, Boutron-Ruault MC. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis 2016;22:345-54. [PMID: 26717318 DOI: 10.1097/MIB.0000000000000638] [Cited by in Crossref: 157] [Cited by in F6Publishing: 136] [Article Influence: 22.4] [Reference Citation Analysis]
454 Pugmire BS, Gee MS, Kaplan JL, Hahn PF, Doody DP, Winter HS, Gervais DA. Role of percutaneous abscess drainage in the management of young patients with Crohn disease. Pediatr Radiol 2016;46:653-9. [DOI: 10.1007/s00247-015-3533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
455 Buderus S, Scholz D, Behrens R, Classen M, De Laffolie J, Keller KM, Zimmer KP, Koletzko S; CEDATA-GPGE Study Group. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. Dtsch Arztebl Int 2015;112:121-7. [PMID: 25759978 DOI: 10.3238/arztebl.2015.0121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
456 Imanzadeh F, Nasri P, Sadeghi S, Sayyari A, Dara N, Abdollah K, Nilipoor Y, Mansuri M, Khatami K, Rouhani P, Olang B. Food allergy among Iranian children with inflammatory bowel disease: A preliminary report. J Res Med Sci 2015;20:855-9. [PMID: 26759572 DOI: 10.4103/1735-1995.170605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
457 Higuchi LM, Regan BP, Bousvaros A. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_30] [Reference Citation Analysis]
458 Kelly D, Alenghat T. Epigenomics of Intestinal Disease. Medical Epigenetics 2016. [DOI: 10.1016/b978-0-12-803239-8.00015-6] [Reference Citation Analysis]
459 Nuti F, Civitelli F, Bloise S, Oliva S, Aloi M, Latorre G, Viola F, Cucchiara S. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort. J Crohns Colitis 2016;10:5-12. [PMID: 26188350 DOI: 10.1093/ecco-jcc/jjv126] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
460 Cucchiara S, Aloi M. Crohn’s Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_28] [Reference Citation Analysis]
461 Holtman GA, Lisman-van Leeuwen Y, Reitsma JB, Berger MY. Noninvasive Tests for Inflammatory Bowel Disease: A Meta-analysis. Pediatrics 2016;137. [PMID: 26681783 DOI: 10.1542/peds.2015-2126] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
462 El-matary W, Otley A, Critch J, Abou-setta AM. Enteral Feeding Therapy for Maintaining Remission in Crohn’s Disease: A Systematic Review. JPEN J Parenter Enteral Nutr 2017;41:550-61. [DOI: 10.1177/0148607115621051] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
463 Zhang L, Zhang W, Hou SC. Nutritional support in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(34): 5427-5434 [DOI: 10.11569/wcjd.v23.i34.5427] [Reference Citation Analysis]
464 Lachaux A. Endoscopie digestive et maladies inflammatoires chroniques de l’intestin en pédiatrie. Acta Endosc 2015;45:325-330. [DOI: 10.1007/s10190-015-0510-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
465 Buttó LF, Schaubeck M, Haller D. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol 2015;6:555. [PMID: 26635787 DOI: 10.3389/fimmu.2015.00555] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
466 Kammermeier J, Morris MA, Garrick V, Furman M, Rodrigues A, Russell RK. Management of Crohn’s disease. Arch Dis Child. 2016;101:475-480. [PMID: 26553907 DOI: 10.1136/archdischild-2014-307217] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
467 Van Der Kraak L, Gros P, Beauchemin N. Colitis-associated colon cancer: Is it in your genes? World J Gastroenterol 2015; 21(41): 11688-11699 [PMID: 26556996 DOI: 10.3748/wjg.v21.i41.11688] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
468 Zhang FM, Xu CF, Shan GD, Chen HT, Xu GQ. Is gallstone disease associated with inflammatory bowel diseases? A meta-analysis. J Dig Dis 2015;16:634-41. [PMID: 26332254 DOI: 10.1111/1751-2980.12286] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
469 Greenley RN, Gumidyala AP, Nguyen E, Plevinsky JM, Poulopoulos N, Thomason MM, Walter JG, Wojtowicz AA, Blank E, Gokhale R, Kirschner BS, Miranda A, Noe JD, Stephens MC, Werlin S, Kahn SA. Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial. Inflamm Bowel Dis 2015;21:2649-57. [PMID: 26218142 DOI: 10.1097/MIB.0000000000000530] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
470 Scherkenbach LA, Stumpf JL. Methotrexate for the Management of Crohn's Disease in Children. Ann Pharmacother 2016;50:60-9. [PMID: 26511908 DOI: 10.1177/1060028015613527] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
471 Koike Y, Uchida K, Inoue M, Ide S, Hashimoto K, Matsushita K, Otake K, Ohkita Y, Araki T, Kobayashi M, Mohri Y, Kusunoki M. Infantile Crohn's disease is one of the risk factors for catheter-related bloodstream infection. Pediatr Int 2014;56:364-8. [PMID: 24517844 DOI: 10.1111/ped.12304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
472 Cakir M, Unal F, Dinler G, Baran M, Yuksekkaya HA, Tumgor G, Kasirga E, Kalayci AG, Aydogdu S. Inflammatory bowel disease in Turkish children. World J Pediatr 2015;11:331-7. [DOI: 10.1007/s12519-015-0042-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
473 Vitale DS, Greenley RN, Lerner DG, Mavis AM, Werlin SL. Adherence to Infliximab Treatment in a Pediatric Inflammatory Bowel Disease Cohort. J Pediatr Gastroenterol Nutr 2015;61:408-10. [PMID: 25885878 DOI: 10.1097/MPG.0000000000000817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
474 Chhaya V, Pollok RC, Cecil E, Subramanian V, Curcin V, Majeed A, Saxena S. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study. Aliment Pharmacol Ther 2015;42:990-9. [PMID: 26271196 DOI: 10.1111/apt.13361] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
475 Doshi-Velez F, Avillach P, Palmer N, Bousvaros A, Ge Y, Fox K, Steinberg G, Spettell C, Juster I, Kohane I. Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders. Inflamm Bowel Dis 2015;21:2281-8. [PMID: 26218138 DOI: 10.1097/MIB.0000000000000502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
476 Malmborg P, Hildebrand H. The emerging global epidemic of paediatric inflammatory bowel disease--causes and consequences. J Intern Med. 2016;279:241-258. [PMID: 26355194 DOI: 10.1111/joim.12413] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
477 Carpio D, Barreiro-de Acosta M, Echarri A, Pereira S, Castro J, Ferreiro R, Lorenzo A; EIGA Group (Grupo Gallego de Enfermedad Inflamatoria Intestinal). Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. Eur J Gastroenterol Hepatol 2015;27:1030-7. [PMID: 26049704 DOI: 10.1097/MEG.0000000000000395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
478 Huth K, Benchimol EI, Aglipay M, Mack DR. Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access. Inflamm Bowel Dis 2015;21:1761-8. [PMID: 26199989 DOI: 10.1097/MIB.0000000000000425] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
479 Ashton JJ, Coelho T, Ennis S, Batra A, Afzal NA, Beattie RM. Presenting phenotype of paediatric inflammatory bowel disease in Wessex, Southern England 2010-2013. Acta Paediatr 2015;104:831-7. [PMID: 25847524 DOI: 10.1111/apa.13017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
480 Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015;50:942-51. [PMID: 25687629 DOI: 10.3109/00365521.2015.1014407] [Cited by in Crossref: 221] [Cited by in F6Publishing: 211] [Article Influence: 27.6] [Reference Citation Analysis]
481 Nuti F, Fiorino G, Danese S. Adalimumab for the treatment of pediatric Crohn’s disease. Expert Review of Clinical Immunology 2015;11:963-72. [DOI: 10.1586/1744666x.2015.1072048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
482 Nahidi L, Corley SM, Wilkins MR, Wei J, Alhagamhmad M, Day AS, Lemberg DA, Leach ST. The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis. Genes Nutr 2015;10:479. [PMID: 26183161 DOI: 10.1007/s12263-015-0479-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
483 Szymanska E, Dadalski M, Oracz G, Kierkus J. Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease. Prz Gastroenterol 2015;10:164-8. [PMID: 26516383 DOI: 10.5114/pg.2015.52298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
484 Walters TD, Hyams JS. Can early anti-TNF-α treatment be an effective therapeutic strategy in children with Crohn's disease? Immunotherapy 2014;6:799-802. [PMID: 25290411 DOI: 10.2217/imt.14.57] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
485 Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol 2015;31:283-9. [PMID: 26039719 DOI: 10.1097/MOG.0000000000000183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
486 Ballard BR, M’Koma AE. Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn’s colitis. World J Gastrointest Endosc 2015; 7(7): 670-674 [PMID: 26140094 DOI: 10.4253/wjge.v7.i7.670] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
487 Heida A, Dijkstra A, Groen H, Muller Kobold A, Verkade H, van Rheenen P. Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials 2015;16:271. [PMID: 26073770 DOI: 10.1186/s13063-015-0787-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
488 Clarke T, Lusher J. Transitioning patients with inflammatory bowel disease (IBD) from adolescent to adult services: a systematic review. Frontline Gastroenterol 2016;7:264-70. [PMID: 28839867 DOI: 10.1136/flgastro-2015-100575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
489 Van Limbergen J, Haskett J, Griffiths AM, Critch J, Huynh H, Ahmed N, deBruyn JC, Issenman R, El-Matary W, Walters TD, Kluthe C, Roy ME, Sheppard E, Crandall WV, Cohen S, Ruemmele FM, Levine A, Otley AR. Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers. Can J Gastroenterol Hepatol 2015;29:351-6. [PMID: 26076398 DOI: 10.1155/2015/509497] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
490 Day AS, Lopez RN. Exclusive enteral nutrition in children with Crohn’s disease. World J Gastroenterol 2015; 21(22): 6809-6816 [PMID: 26078556 DOI: 10.3748/wjg.v21.i22.6809] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
491 Kolho KL, Korpela K, Jaakkola T, Pichai MV, Zoetendal EG, Salonen A, de Vos WM. Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation. Am J Gastroenterol 2015;110:921-30. [PMID: 25986361 DOI: 10.1038/ajg.2015.149] [Cited by in Crossref: 149] [Cited by in F6Publishing: 147] [Article Influence: 18.6] [Reference Citation Analysis]
492 Yang C, Singh P, Singh H, Le ML, El-Matary W. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:1079-93. [PMID: 25858208 DOI: 10.1111/apt.13181] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
493 Fumery M, Jacob A, Sarter H, Michaud L, Spyckerelle C, Mouterde O, Savoye G, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C, Turck D; EPIMAD Group. Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:744-8. [PMID: 26000887 DOI: 10.1097/MPG.0000000000000713] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
494 Nee J, Feuerstein JD. Optimizing the Care and Health of Women with Inflammatory Bowel Disease. Gastroenterol Res Pract 2015;2015:435820. [PMID: 26089868 DOI: 10.1155/2015/435820] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
495 Keethy D, Mrakotsky C, Szigethy E. Pediatric inflammatory bowel disease and depression: treatment implications. Curr Opin Pediatr 2014;26:561-7. [PMID: 25010217 DOI: 10.1097/MOP.0000000000000129] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
496 Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015;167:527-532.e1-3. [PMID: 25982142 DOI: 10.1016/j.jpeds.2015.04.045] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
497 Bollegala N, Nguyen GC. Transitioning the Adolescent with IBD from Pediatric to Adult Care: A Review of the Literature. Gastroenterol Res Pract. 2015;2015:853530. [PMID: 26064100 DOI: 10.1155/2015/853530] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
498 Malmborg P, Grahnquist L, Ideström M, Lindholm J, Befrits R, Björk J, Montgomery S, Hildebrand H. Presentation and progression of childhood-onset inflammatory bowel disease in Northern Stockholm County. Inflamm Bowel Dis 2015;21:1098-108. [PMID: 25844958 DOI: 10.1097/MIB.0000000000000356] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
499 Dotson JL, Rosh JR. It Is Prudent to Assess Psychosocial Functioning in Children with Inflammatory Bowel Disease. The Journal of Pediatrics 2015;166:1108-1109. [DOI: 10.1016/j.jpeds.2015.01.014] [Reference Citation Analysis]
500 Kierkuś J, Iwańczak B, Wegner A, Dadalski M, Grzybowska-Chlebowczyk U, Łazowska I, Maślana J, Toporowska-Kowalska E, Czaja-Bulsa G, Mierzwa G, Korczowski B, Czkwianianc E, Żabka A, Szymańska E, Krzesiek E, Więcek S, Sładek M. Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:580-5. [PMID: 25564804 DOI: 10.1097/MPG.0000000000000684] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
501 Gray WN, Holbrook E, Morgan PJ, Saeed SA, Denson LA, Hommel KA. Transition readiness skills acquisition in adolescents and young adults with inflammatory bowel disease: findings from integrating assessment into clinical practice. Inflamm Bowel Dis 2015;21:1125-31. [PMID: 25803505 DOI: 10.1097/MIB.0000000000000352] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
502 Fang K, Grisham MB, Kevil CG. Application of Comparative Transcriptional Genomics to Identify Molecular Targets for Pediatric IBD. Front Immunol. 2015;6:165. [PMID: 26085826 DOI: 10.3389/fimmu.2015.00165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
503 Holmes EA, Xiang F, Lucas RM. Variation in incidence of pediatric Crohn's disease in relation to latitude and ambient ultraviolet radiation: a systematic review and analysis. Inflamm Bowel Dis 2015;21:809-17. [PMID: 25789921 DOI: 10.1097/MIB.0000000000000320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
504 Sandberg KC, Davis MM, Gebremariam A, Adler J. Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011. J Pediatr Gastroenterol Nutr 2015;60:486-92. [PMID: 25419679 DOI: 10.1097/MPG.0000000000000636] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
505 Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, Quach P, Manuel DG. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 2015;110:553-63. [PMID: 25756238 DOI: 10.1038/ajg.2015.52] [Cited by in Crossref: 158] [Cited by in F6Publishing: 151] [Article Influence: 19.8] [Reference Citation Analysis]
506 Dotson JL, Kappelman MD, Chisolm DJ, Crandall WV. Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis 2015;21:801-8. [PMID: 25742396 DOI: 10.1097/MIB.0000000000000325] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 6.1] [Reference Citation Analysis]
507 Kolho KL, Taskinen S, Rintala RJ. Pediatric urology patients with megaureter may have a risk of contracting Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:211-3. [PMID: 25272323 DOI: 10.1097/MPG.0000000000000581] [Reference Citation Analysis]
508 Mann GS, Greer MC, Nadel HR. Paediatric Crohn’s Disease. Crohn's Disease 2015. [DOI: 10.1007/978-3-319-01913-0_10] [Reference Citation Analysis]
509 Li J, Butcher J, Mack D, Stintzi A. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2015;21:139-53. [PMID: 25248007 DOI: 10.1097/MIB.0000000000000215] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 10.5] [Reference Citation Analysis]
510 Ledder O, Lemberg DA, Day AS. Thiopurine-induced pancreatitis in inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol 2015;9:399-403. [PMID: 25494551 DOI: 10.1586/17474124.2015.992879] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
511 El-Matary W, Moroz SP, Bernstein CN. Inflammatory bowel disease in children of Manitoba: 30 years' experience of a tertiary center. J Pediatr Gastroenterol Nutr 2014;59:763-6. [PMID: 25111222 DOI: 10.1097/MPG.0000000000000525] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
512 Olén O, Neuman Å, Koopmann B, Ludvigsson JF, Ballardini N, Westman M, Melén E, Kull I, Simrén M, Bergström A. Allergy-related diseases and recurrent abdominal pain during childhood - a birth cohort study. Aliment Pharmacol Ther 2014;40:1349-58. [PMID: 25270840 DOI: 10.1111/apt.12965] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
513 Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D, Klein C, Snapper SB, Muise AM; COLORS in IBD Study Group and NEOPICS. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology 2014;147:990-1007.e3. [PMID: 25058236 DOI: 10.1053/j.gastro.2014.07.023] [Cited by in Crossref: 413] [Cited by in F6Publishing: 456] [Article Influence: 45.9] [Reference Citation Analysis]
514 Hein R, Köster I, Bollschweiler E, Schubert I. Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scand J Gastroenterol 2014;49:1325-35. [PMID: 25259808 DOI: 10.3109/00365521.2014.962605] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
515 Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL; ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis 2014;8:1351-61. [PMID: 24951261 DOI: 10.1016/j.crohns.2014.05.006] [Cited by in Crossref: 103] [Cited by in F6Publishing: 70] [Article Influence: 11.4] [Reference Citation Analysis]
516 Kulungowski AM, Acker SN, Hoffenberg EJ, Neigut D, Partrick DA. Initial operative treatment of isolated ileal Crohn's disease in adolescents. Am J Surg 2015;210:141-5. [PMID: 25457242 DOI: 10.1016/j.amjsurg.2014.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
517 Benchimol EI, Mack DR, Nguyen GC, Snapper SB, Li W, Mojaverian N, Quach P, Muise AM. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 2014;147:803-813.e7; quiz e14-5. [PMID: 24951840 DOI: 10.1053/j.gastro.2014.06.023] [Cited by in Crossref: 172] [Cited by in F6Publishing: 174] [Article Influence: 19.1] [Reference Citation Analysis]
518 Bitton A, Vutcovici M, Patenaude V, Sewitch M, Suissa S, Brassard P. Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis 2014;20:1770-6. [PMID: 25159452 DOI: 10.1097/MIB.0000000000000162] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
519 Benchimol EI, Manuel DG, Guttmann A, Nguyen GC, Mojaverian N, Quach P, Mack DR. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 2014;20:1761-9. [PMID: 25159453 DOI: 10.1097/MIB.0000000000000103] [Cited by in Crossref: 136] [Cited by in F6Publishing: 110] [Article Influence: 15.1] [Reference Citation Analysis]
520 Adams AT, Kennedy NA, Hansen R, Ventham NT, OʼLeary KR, Drummond HE, Noble CL, El-Omar E, Russell RK, Wilson DC, Nimmo ER, Hold GL, Satsangi J. Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis 2014;20:1784-93. [PMID: 25144570 DOI: 10.1097/MIB.0000000000000179] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
521 Sandberg KC, Davis MM, Gebremariam A, Adler J. Increasing hospitalizations in inflammatory bowel disease among children in the United States, 1988-2011. Inflamm Bowel Dis 2014;20:1754-60. [PMID: 25185689 DOI: 10.1097/MIB.0000000000000195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
522 Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J, Amil Dias J, Barabino A, Braegger C, Bronsky J, Buderus S, Martín-de-carpi J, De Ridder L, Fagerberg U, Hugot J, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López V, Paerregaard A, Russell R, Serban D, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's and Colitis 2014;8:1179-207. [DOI: 10.1016/j.crohns.2014.04.005] [Cited by in Crossref: 694] [Cited by in F6Publishing: 702] [Article Influence: 77.1] [Reference Citation Analysis]
523 de Meij TG, de Boer NK, Benninga MA, Lentferink YE, de Groot EF, van de Velde ME, van Bodegraven AA, van der Schee MP. Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study. J Crohns Colitis 2014:S1873-9946(14)00285-2. [PMID: 25248313 DOI: 10.1016/j.crohns.2014.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
524 Jianzhong H. The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease. Clin Lab Med 2014;34:763-70. [PMID: 25439275 DOI: 10.1016/j.cll.2014.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
525 Kammermeier J, Drury S, James CT, Dziubak R, Ocaka L, Elawad M, Beales P, Lench N, Uhlig HH, Bacchelli C. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease--evaluation and prospective analysis. J Med Genet. 2014;51:748-755. [PMID: 25194001 DOI: 10.1136/jmedgenet-2014-102624] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
526 Dulai PS, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol 2014;12:1443-51; quiz e88-9. [PMID: 24462626 DOI: 10.1016/j.cgh.2014.01.021] [Cited by in Crossref: 107] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
527 Bhoola PH, Shtofmakher G, Bahri A, Patel AA, Barlizo SR, Trepal M. Pedal Gangrenous Changes in the Digits of an Adolescent With Ulcerative Colitis: A Case Report. J Foot Ankle Surg. 2014; Aug 16. [Epub ahead of print]. [PMID: 25135104 DOI: 10.1053/j.jfas.2014.06.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
528 Rigoli L, Caruso RA. Inflammatory bowel disease in pediatric and adolescent patients: A biomolecular and histopathological review. World J Gastroenterol 2014; 20(30): 10262-10278 [PMID: 25132743 DOI: 10.3748/wjg.v20.i30.10262] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
529 Bryant RV, Trott MJ, Bennett A, Bampton PA, Moore DJ, Andrews JM. Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Intern Med J. 2013;43:1171-1176. [PMID: 24237644 DOI: 10.1111/imj.12272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
530 Leddin D, Tamim H, Levy AR. Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol. 2014;14:140. [PMID: 25108544 DOI: 10.1186/1471-230x-14-140] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
531 Benchimol EI, Guttmann A, Mack DR, Nguyen GC, Marshall JK, Gregor JC, Wong J, Forster AJ, Manuel DG. Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. Journal of Clinical Epidemiology 2014;67:887-96. [DOI: 10.1016/j.jclinepi.2014.02.019] [Cited by in Crossref: 113] [Cited by in F6Publishing: 128] [Article Influence: 12.6] [Reference Citation Analysis]
532 Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E, Navas-López VM; SPIRIT-IBD Working Group of SEGHNP (Sociedad Española de Gastroenterología Hepatología Nutrición Pediátrica). The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry. J Crohns Colitis 2014;8:763-9. [PMID: 24462789 DOI: 10.1016/j.crohns.2014.01.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
533 de Silva PS, Fishman LN. Transition of the patient with IBD from pediatric to adult care-an assessment of current evidence. Inflamm Bowel Dis 2014;20:1458-64. [PMID: 24846721 DOI: 10.1097/MIB.0000000000000045] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
534 Springmann V, Brassard P, Krupoves A, Amre D. Timing, frequency and type of physician-diagnosed infections in childhood and risk for Crohn's disease in children and young adults. Inflamm Bowel Dis 2014;20:1346-52. [PMID: 25046007 DOI: 10.1097/MIB.0000000000000098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
535 Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV. Routine use of thiopurines in maintaining remission in pediatric Crohn’s disease. World J Gastroenterol 2014; 20(27): 9185-9190 [PMID: 25083093 DOI: 10.3748/wjg.v20.i27.9185] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
536 Lemberg DA, Day AS. Crohn disease and ulcerative colitis in children: an update for 2014. J Paediatr Child Health. 2015;51:266-270. [PMID: 25039307 DOI: 10.1111/jpc.12685] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
537 Salim SY, Jovel J, Wine E, Kaplan GG, Vincent R, Thiesen A, Barkema HW, Madsen KL. Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice. Inflamm Bowel Dis 2014;20:1129-38. [PMID: 24859295 DOI: 10.1097/MIB.0000000000000066] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
538 Xu L, Dai WQ, Wang F, He L, Zhou YQ, Lu J, Xu XF, Guo CY. Association of STAT4 gene rs7574865G > T polymorphism with ulcerative colitis risk: evidence from 1532 cases and 3786 controls. Arch Med Sci 2014;10:419-24. [PMID: 25097569 DOI: 10.5114/aoms.2014.43735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
539 Mandel MD, Miheller P, Müllner K, Golovics PA, Lakatos PL. Have biologics changed the natural history of Crohn's disease? Dig Dis 2014;32:351-9. [PMID: 24969279 DOI: 10.1159/000358135] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
540 Naidoo CM, Leach ST, Day AS, Lemberg DA. Inflammatory bowel disease in children of middle eastern descent. Int J Pediatr. 2014;2014:906128. [PMID: 24987422 DOI: 10.1155/2014/906128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
541 Uusijärvi A, Bergström A, Simrén M, Ludvigsson JF, Kull I, Wickman M, Alm J, Olén O. Use of antibiotics in infancy and childhood and risk of recurrent abdominal pain--a Swedish birth cohort study. Neurogastroenterol Motil 2014;26:841-50. [PMID: 24708246 DOI: 10.1111/nmo.12340] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
542 El Mouzan MI, Saadah O, Al-Saleem K, Al Edreesi M, Hasosah M, Alanazi A, Al Mofarreh M, Asery A, Al Qourain A, Nouli K, Al Hussaini A, Telmesani A, AlReheili K, Alghamdi S, Alrobiaa N, Alzaben A, Mehmadi A, Al Hebbi H, Al Sarkhy A, Al Mehaidib A, Al Saleem B, Assiri A, Wali S. Incidence of pediatric inflammatory bowel disease in Saudi Arabia: a multicenter national study. Inflamm Bowel Dis 2014;20:1085-90. [PMID: 24788219 DOI: 10.1097/MIB.0000000000000048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
543 ten Bruggencate SJ, Bovee-Oudenhoven IM, Feitsma AL, van Hoffen E, Schoterman MH. Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutr Rev 2014;72:377-89. [PMID: 24828428 DOI: 10.1111/nure.12106] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 11.7] [Reference Citation Analysis]
544 Pant C, Deshpande A, Olyaee M, Anderson MP, Bitar A, Steele MI, Bass PF, Sferra TJ. Epidemiology of acute pancreatitis in hospitalized children in the United States from 2000-2009. PLoS One. 2014;9:e95552. [PMID: 24805879 DOI: 10.1371/journal.pone.0095552] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
545 Kovács M, Müller KE, Papp M, Lakatos PL, Csöndes M, Veres G. New serological markers in pediatric patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(17): 4873-4882 [PMID: 24803798 DOI: 10.3748/wjg.v20.i17.4873] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
546 Nuti F, Viola F, Civitelli F, Alessandri C, Aloi M, Dilillo A, Del Giudice E, Cucchiara S. Biological therapy in a pediatric Crohn disease population at a referral center. J Pediatr Gastroenterol Nutr 2014;58:582-7. [PMID: 24343280 DOI: 10.1097/MPG.0000000000000276] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
547 Lovasz BD, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Balogh M, Szipocs I, Vegh Z, Veres G, Müller KE, Golovics PA, Kiss LS, Mandel MD, Lakatos PL. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Dig Liver Dis 2014;46:405-11. [PMID: 24495511 DOI: 10.1016/j.dld.2013.12.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
548 Lei P, Gu F, Hong L, Sun Y, Li M, Wang H, Zhong B, Chen M, Cui Y, Zhang S. Pediatric colonoscopy in South China: a 12-year experience in a tertiary center. PLoS One 2014;9:e95933. [PMID: 24759776 DOI: 10.1371/journal.pone.0095933] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
549 Hu D, Ren J, Wang G, Gu G, Liu S, Wu X, Chen J, Ren H, Hong Z, Li J. Geographic mapping of Crohn’s disease and its relation to affluence in jiangsu province, an eastern coastal province of china. Gastroenterol Res Pract. 2014;2014:590467. [PMID: 24839438 DOI: 10.1155/2014/590467] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
550 Ashton JJ, Wiskin AE, Ennis S, Batra A, Afzal NA, Beattie RM. Rising incidence of paediatric inflammatory bowel disease (PIBD) in Wessex, Southern England. Arch Dis Child. 2014;99:659-664. [PMID: 24728445 DOI: 10.1136/archdischild-2013-305419] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
551 Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis 2014;8:288-95. [PMID: 24074875 DOI: 10.1016/j.crohns.2013.09.001] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 13.7] [Reference Citation Analysis]
552 Hummel TZ, Kindermann A, Stokkers PC, Benninga MA, ten Kate FJ. Exogenous pigment in Peyer patches of children suspected of having IBD. J Pediatr Gastroenterol Nutr 2014;58:477-80. [PMID: 24164906 DOI: 10.1097/MPG.0000000000000221] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
553 Kolho KL, Sipponen T. The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease. Scand J Gastroenterol 2014;49:434-41. [PMID: 24597837 DOI: 10.3109/00365521.2014.886719] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
554 Day AS, Lemberg DA, Gearry RB. Inflammatory bowel disease in australasian children and adolescents. Gastroenterol Res Pract 2014;2014:703890. [PMID: 24799892 DOI: 10.1155/2014/703890] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
555 Sidoroff M, Kolho KL. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy. BMC Gastroenterol 2014;14:51. [PMID: 24661924 DOI: 10.1186/1471-230X-14-51] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
556 Eszter Müller K, Laszlo Lakatos P, Papp M, Veres G. Incidence and paris classification of pediatric inflammatory bowel disease. Gastroenterol Res Pract 2014;2014:904307. [PMID: 24778643 DOI: 10.1155/2014/904307] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
557 Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Mäkitie O. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. J Pediatr 2014;164:1436-43.e1. [PMID: 24650398 DOI: 10.1016/j.jpeds.2014.01.073] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
558 Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis 2014;20:398-415. [PMID: 24280882 DOI: 10.1097/01.MIB.0000435441.30107.8b] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
559 Aloi M, Nuti F, Stronati L, Cucchiara S. Advances in the medical management of paediatric IBD. Nat Rev Gastroenterol Hepatol 2014;11:99-108. [PMID: 23958601 DOI: 10.1038/nrgastro.2013.158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
560 Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014;11:88-98. [PMID: 24345891 DOI: 10.1038/nrgastro.2013.240] [Cited by in Crossref: 139] [Cited by in F6Publishing: 109] [Article Influence: 15.4] [Reference Citation Analysis]
561 Dhillon SS, Mastropaolo LA, Murchie R, Griffiths C, Thöni C, Elkadri A, Xu W, Mack A, Walters T, Guo C, Mack D, Huynh H, Baksh S, Silverberg MS, Brumell JH, Snapper SB, Muise AM. Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clin Transl Gastroenterol 2014;5:e46. [PMID: 24430113 DOI: 10.1038/ctg.2013.17] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
562 Bishop J, Lemberg DA, Day A. Managing inflammatory bowel disease in adolescent patients. Adolesc Health Med Ther. 2014;5:1-13. [PMID: 24729736 DOI: 10.2147/ahmt.s37956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
563 Farrell KE, Keely S, Graham BA, Callister R, Callister RJ. A systematic review of the evidence for central nervous system plasticity in animal models of inflammatory-mediated gastrointestinal pain. Inflamm Bowel Dis 2014;20:176-95. [PMID: 24284415 DOI: 10.1097/01.MIB.0000437499.52922.b1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
564 Song Y, Dunkin D, Dahan S, Iuga A, Ceballos C, Hoffstadter-Thal K, Yang N, Benkov K, Mayer L, Li XM. Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD. Inflamm Bowel Dis 2014;20:144-53. [PMID: 24252977 DOI: 10.1097/01.MIB.0000436467.37566.48] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
565 Crandall WV, Baldassano R, Bousvaros A, Denson LA, Gupta N, Mackner LM. NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr 2014;58:130-8. [PMID: 24378522 DOI: 10.1097/MPG.0000000000000178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
566 Jacobson K, Calder PC. Role of Omega-6 and Omega-3 Fatty Acids in Inflammatory Bowel Disease. Pharma-Nutrition 2014. [DOI: 10.1007/978-3-319-06151-1_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
567 Albenberg L, Baldassano RN, Kelsen J. Pediatric Issues in Treating Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_25] [Reference Citation Analysis]
568 Small CL, Reid-Yu SA, McPhee JB, Coombes BK. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun. 2013;4:1957. [PMID: 23748852 DOI: 10.1038/ncomms2957] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 10.3] [Reference Citation Analysis]
569 Gasparetto M, Guariso G. Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age. Gastroenterol Res Pract. 2013;2013:829040. [PMID: 24454343 DOI: 10.1155/2013/829040] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
570 Aloi M, D'Arcangelo G, Pofi F, Vassallo F, Rizzo V, Nuti F, Di Nardo G, Pierdomenico M, Viola F, Cucchiara S. Presenting features and disease course of pediatric ulcerative colitis. J Crohns Colitis 2013;7:e509-15. [PMID: 23583691 DOI: 10.1016/j.crohns.2013.03.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
571 De Greef E, Mahachie John JM, Hoffman I, Smets F, Van Biervliet S, Scaillon M, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, Peeters H, Baert F, D'Haens G, Rahier JF, Etienne I, Bauraind O, Van Gossum A, Vermeire S, Fontaine F, Muls V, Louis E, Van de Mierop F, Coche JC, Van Steen K, Veereman G; IBD working group of the Belgian Society of Pediatric Gastroenterology, Hepatology and Nutrition (BeSPGHAN), Belgian IBD Research and Development. Profile of pediatric Crohn's disease in Belgium. J Crohns Colitis 2013;7:e588-98. [PMID: 23664896 DOI: 10.1016/j.crohns.2013.04.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
572 Dulai PS, Siegel CA, Dubinsky MC. Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2927-36. [PMID: 23867874 DOI: 10.1097/MIB.0b013e31829aad16] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
573 Agnarsson U, Björnsson S, Jóhansson JH, Sigurdsson L. Inflammatory bowel disease in Icelandic children 1951-2010. Population-based study involving one nation over six decades. Scand J Gastroenterol 2013;48:1399-404. [PMID: 24164345 DOI: 10.3109/00365521.2013.845799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
574 Aloi M, Cucchiara S, Martino M, Semelka RC, Tomei E. Growth Failure and Pediatric Inflammatory Bowel Disease. Text-Atlas of Skeletal Age Determination 2013. [DOI: 10.1002/9781118692202.ch10] [Reference Citation Analysis]
575 Foster A, Jacobson K. Changing incidence of inflammatory bowel disease: environmental influences and lessons learnt from the South asian population. Front Pediatr. 2013;1:34. [PMID: 24400280 DOI: 10.3389/fped.2013.00034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
576 Müller KE, Lakatos PL, Arató A, Kovács JB, Várkonyi Á, Szűcs D, Szakos E, Sólyom E, Kovács M, Polgár M, Nemes É, Guthy I, Tokodi I, Tóth G, Horváth Á, Tárnok A, Csoszánszki N, Balogh M, Vass N, Bódi P, Dezsőfi A, Gárdos L, Micskey E, Papp M, Cseh Á, Szabó D, Vörös P, Veres G; Hungarian IBD Registry Group (HUPIR). Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57:576-82. [PMID: 23820399 DOI: 10.1097/MPG.0b013e31829f7d8c] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
577 Ceriati E, De Peppo F, Rivosecchi M. Role of surgery in pediatric ulcerative colitis. Pediatr Surg Int. 2013;29:1231-1241. [PMID: 24173816 DOI: 10.1007/s00383-013-3425-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
578 Aujnarain A, Mack DR, Benchimol EI. The role of the environment in the development of pediatric inflammatory bowel disease. Curr Gastroenterol Rep 2013;15:326. [PMID: 23640032 DOI: 10.1007/s11894-013-0326-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
579 Quach P, Nguyen GC, Benchimol EI. Quality improvement in pediatric inflammatory bowel disease: Moving forward to improve outcomes. World J Gastroenterol 2013; 19(38): 6367-6374 [PMID: 24151355 DOI: 10.3748/wjg.v19.i38.6367] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
580 Zijlstra M, De Bie C, Breij L, van Pieterson M, van Staa A, de Ridder L, van der Woude J, Escher J. Self-efficacy in adolescents with inflammatory bowel disease: a pilot study of the "IBD-yourself", a disease-specific questionnaire. J Crohns Colitis 2013;7:e375-85. [PMID: 23537816 DOI: 10.1016/j.crohns.2013.02.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
581 Debruyn JC, Soon IS, Hubbard J, Wrobel I, Panaccione R, Kaplan GG. Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009. Inflamm Bowel Dis 2013;19:2423-32. [PMID: 23974991 DOI: 10.1097/MIB.0b013e3182a56148] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
582 Strisciuglio C, Miele E, Wildenberg ME, Giugliano FP, Andreozzi M, Vitale A, Capasso F, Camarca A, Barone MV, Staiano A, Troncone R, Gianfrani C. T300A variant of autophagy ATG16L1 gene is associated with decreased antigen sampling and processing by dendritic cells in pediatric Crohn's disease. Inflamm Bowel Dis 2013;19:2339-48. [PMID: 24022642 DOI: 10.1097/MIB.0b013e3182a6a11c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
583 M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33-47. [PMID: 24833941 DOI: 10.4137/cgast.s12731] [Cited by in Crossref: 146] [Cited by in F6Publishing: 174] [Article Influence: 14.6] [Reference Citation Analysis]
584 Levi Z, Shamiss A, Fraser GM, Furman M, Derazne E, Tzur D, Gordon B, Welinsky S, Gingold Belfer R, Afek A. The increasing prevalence of inflammatory bowel diseases among Jewish adolescents and the sociodemographic factors associated with diagnosis. Inflamm Bowel Dis 2013;19:1867-71. [PMID: 23665967 DOI: 10.1097/MIB.0b013e31828a3797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
585 Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;5:237-247. [PMID: 23922506 DOI: 10.2147/clep.s33961] [Cited by in Crossref: 46] [Cited by in F6Publishing: 103] [Article Influence: 4.6] [Reference Citation Analysis]
586 Malmborg P, Grahnquist L, Lindholm J, Montgomery S, Hildebrand H. Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007. J Pediatr Gastroenterol Nutr 2013;57:29-34. [PMID: 23459320 DOI: 10.1097/MPG.0b013e31828f21b4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
587 Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013;29:357-62. [PMID: 23695429 DOI: 10.1097/MOG.0b013e32836229fb] [Cited by in Crossref: 107] [Cited by in F6Publishing: 114] [Article Influence: 10.7] [Reference Citation Analysis]
588 Maranghi F, Tassinari R, Mantovani A. Toxicological assessment of drugs that affect the endocrine system in puberty-related disorders. Expert Opin Drug Metab Toxicol 2013;9:1309-16. [PMID: 23790205 DOI: 10.1517/17425255.2013.811488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
589 Malaty HM, Abraham BP, Mehta S, Garnett EA, Ferry GD. The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study. Clin Exp Gastroenterol 2013;6:77-83. [PMID: 23825926 DOI: 10.2147/CEG.S40259] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
590 Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Rev Clin Immunol. 2013;9:65-75; quiz 76. [PMID: 23256765 DOI: 10.1586/eci.12.86] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
591 Virta LJ, Ashorn M, Kolho KL. Cow's milk allergy, asthma, and pediatric IBD. J Pediatr Gastroenterol Nutr 2013;56:649-51. [PMID: 23319082 DOI: 10.1097/MPG.0b013e318285e9d8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
592 Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC, Puntis J, Cosgrove M, Tamok A, Rao P, Down C, Arnott ID, Mitton SG. Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom. Inflamm Bowel Dis 2013;19:1434-40. [PMID: 23624885 DOI: 10.1097/MIB.0b013e31828133d6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
593 Wolk O, Epstein S, Ioffe-Dahan V, Ben-Shabat S, Dahan A. New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities. Expert Opin Drug Deliv 2013;10:1275-86. [PMID: 23721560 DOI: 10.1517/17425247.2013.800480] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
594 Leu SB, Shulman SC, Steelman CK, Lamps LW, Bulut OP, Abramowsky CR, Gold BD, Szlam S, Stockwell C, Havens J. Pathogenic yersinia DNA in intestinal specimens of pediatric patients with Crohn’s disease. Fetal Pediatr Pathol. 2013;32:367-370. [PMID: 23611062 DOI: 10.3109/15513815.2013.768744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
595 Hansen R, Berry SH, Mukhopadhya I, Thomson JM, Saunders KA, Nicholl CE, Bisset WM, Loganathan S, Mahdi G, Kastner-Cole D, Barclay AR, Bishop J, Flynn DM, McGrogan P, Russell RK, El-Omar EM, Hold GL. The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS One 2013;8:e58825. [PMID: 23554935 DOI: 10.1371/journal.pone.0058825] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
596 Dotson JL, Nwomeh B, Andridge R, Anderson SE, Crandall WV. Variation in management of intra-abdominal abscesses in children with Crohn's disease. Inflamm Bowel Dis 2013;19:818-25. [PMID: 23448793 DOI: 10.1097/MIB.0b013e3182802a1f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
597 Alex G, Cameron D. Pediatric inflammatory bowel disease: can patterns in Asia shed some light? J Gastroenterol Hepatol 2013;28:387-9. [PMID: 23441718 DOI: 10.1111/jgh.12133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
598 Cameron FL, Gerasimidis K, Papangelou A, Missiou D, Garrick V, Cardigan T, Buchanan E, Barclay AR, McGrogan P, Russell RK. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease. Aliment Pharmacol Ther 2013;37:622-9. [PMID: 23360085 DOI: 10.1111/apt.12230] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
599 Medina E. Enfermedad inflamatoria intestinal (I): clasificación, etiología y clínica. Anales de Pediatría Continuada 2013;11:59-67. [DOI: 10.1016/s1696-2818(13)70120-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
600 Wegner A, Szychta M, Kierkuś J. Rola terapii biologicznej w podtrzymaniu remisji u dzieci z chorobą Leśniowskiego i Crohna. Pediatria Polska 2013;88:131-137. [DOI: 10.1016/j.pepo.2012.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
601 Rocchi A, Benchimol EI, Bernstein CN, Bitton A, Feagan B, Panaccione R, Glasgow KW, Fernandes A, Ghosh S. Inflammatory bowel disease: a Canadian burden of illness review. Can J Gastroenterol. 2012;26:811-817. [PMID: 23166905 DOI: 10.1155/2012/984575] [Cited by in Crossref: 174] [Cited by in F6Publishing: 194] [Article Influence: 17.4] [Reference Citation Analysis]
602 Yang LS, Alex G, Catto-Smith AG. The use of biologic agents in pediatric inflammatory bowel disease. Curr Opin Pediatr. 2012;24:609-614. [PMID: 22828183 DOI: 10.1097/mop.0b013e3283574154] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
603 Jakobsen C, Paerregaard A, Munkholm P, Wewer V. Environmental factors and risk of developing paediatric inflammatory bowel disease -- a population based study 2007-2009. J Crohns Colitis 2013;7:79-88. [PMID: 22748696 DOI: 10.1016/j.crohns.2012.05.024] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
604 de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, Escher JC; EUROKIDS Porto IBD Working Group of ESPGHAN. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19:378-85. [PMID: 22573581 DOI: 10.1002/ibd.23008] [Cited by in Crossref: 110] [Cited by in F6Publishing: 118] [Article Influence: 11.0] [Reference Citation Analysis]
605 Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G. Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review. Dig Dis Sci 2013;58:309-19. [PMID: 22899243 DOI: 10.1007/s10620-012-2347-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
606 El Mouzan M, Al-Mofarreh M, Assiri A, Hamid Y, Saeed A. Consanguinity and inflammatory bowel diseases: is there a relation? J Pediatr Gastroenterol Nutr 2013;56:182-5. [PMID: 22903011 DOI: 10.1097/MPG.0b013e31826d9987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
607 Saeed S, Kugathasan S. Epidemiology of Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_5] [Reference Citation Analysis]
608 Tavares M, Lima R, Soro I, Trindade E, Dias JA. Atividade da doença de Crohn e crescimento. GE Jornal Português de Gastrenterologia 2013;20:3-9. [DOI: 10.1016/j.jpg.2012.06.004] [Reference Citation Analysis]
609 Hämäläinen A, Sipponen T, Kolho KL. Serum infliximab concentrations in pediatric inflammatory bowel disease. Scand J Gastroenterol 2013;48:35-41. [PMID: 23148710 DOI: 10.3109/00365521.2012.741619] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
610 Little JW, Falace DA, Miller CS, Rhodus NL. Gastrointestinal Disease. Little and Falace's Dental Management of the Medically Compromised Patient 2013. [DOI: 10.1016/b978-0-323-08028-6.00011-7] [Reference Citation Analysis]
611 Martín-de-Carpi J, Rodríguez A, Ramos E, Jiménez S, Martínez-Gómez MJ, Medina E; SPIRIT-IBD Working Group of Sociedad Española de Gastroenterología, Hepatología y Nutricion Pediátrica. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry. Inflamm Bowel Dis 2013;19:73-80. [PMID: 22535573 DOI: 10.1002/ibd.22980] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
612 Tarlton NJ, Green CM, Lazarus NH, Rott L, Wong AP, Abramson ON, Bremer M, Butcher EC, Abramson T. Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis. Inflamm Bowel Dis 2012;18:2381-91. [PMID: 22488927 DOI: 10.1002/ibd.22962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
613 Hansen R, Russell RK, Reiff C, Louis P, McIntosh F, Berry SH, Mukhopadhya I, Bisset WM, Barclay AR, Bishop J, Flynn DM, McGrogan P, Loganathan S, Mahdi G, Flint HJ, El-Omar EM, Hold GL. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012;107:1913-22. [PMID: 23044767 DOI: 10.1038/ajg.2012.335] [Cited by in Crossref: 206] [Cited by in F6Publishing: 209] [Article Influence: 18.7] [Reference Citation Analysis]
614 Uchida K, Araki T, Kusunoki M. History of and current issues affecting surgery for pediatric ulcerative colitis. Surg Today 2013;43:1219-31. [PMID: 23203770 DOI: 10.1007/s00595-012-0434-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
615 Uchida K, Kawamata A, Hashimoto K, Inoue M, Otake K, Koike Y, Matsushita K, Fujikawa H, Okita Y, Araki T, Tanaka K, Kusunoki M. Self-reported assessment of health-related quality of life in children who underwent restorative proctocolectomy with ileal J-pouch anal anastomosis for ulcerative colitis. Pediatr Surg Int 2013;29:287-91. [DOI: 10.1007/s00383-012-3224-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
616 Momotani E, Ozaki H, Hori M, Yamamoto S, Kuribayashi T, Eda S, Ikegami M. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn's disease-type necrotizing colitis in Mice. Springerplus 2012;1:47. [PMID: 23519342 DOI: 10.1186/2193-1801-1-47] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
617 Shaw SY, Blanchard JF, Bernstein CN. Association between early childhood otitis media and pediatric inflammatory bowel disease: an exploratory population-based analysis. J Pediatr. 2013;162:510-514. [PMID: 23084703 DOI: 10.1016/j.jpeds.2012.08.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
618 Hosoe N, Nakashita M, Imaeda H, Sujino T, Bessho R, Ichikawa R, Inoue N, Kanai T, Hibi T, Ogata H. Comparison of patient acceptance of sodium phosphate versus polyethylene glycol plus sodium picosulfate for colon cleansing in Japanese. J Gastroenterol Hepatol 2012;27:1617-22. [PMID: 22646064 DOI: 10.1111/j.1440-1746.2012.07190.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
619 Cucchiara S, Stronati L, Aloi M. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease. J Clin Gastroenterol 2012;46 Suppl:S64-6. [PMID: 22955361 DOI: 10.1097/MCG.0b013e31826a857f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
620 Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, Dias JA, Bronsky J, Braegger CP, Cucchiara S, de Ridder L, Fagerberg UL, Hussey S, Hugot JP, Kolacek S, Kolho KL, Lionetti P, Paerregaard A, Potapov A, Rintala R, Serban DE, Staiano A, Sweeny B, Veerman G, Veres G, Wilson DC, Ruemmele FM; European Crohn's and Colitis Organization, European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012;55:340-61. [PMID: 22773060 DOI: 10.1097/MPG.0b013e3182662233] [Cited by in Crossref: 275] [Cited by in F6Publishing: 284] [Article Influence: 25.0] [Reference Citation Analysis]
621 Sebastian S, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R, Lindsay JO. The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: differing perceptions from a survey of adult and paediatric gastroenterologists. J Crohns Colitis 2012;6:830-44. [PMID: 22398082 DOI: 10.1016/j.crohns.2012.01.010] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 8.7] [Reference Citation Analysis]
622 Fitzgerald MP, Mitton SG, Protheroe A, Roughton M, Driscoll R, Arnott IDR, Russell RK. The organisation and structure of inflammatory bowel disease services for children and young people in the UK in 2010: significant progress but still room for improvement. Frontline Gastroenterol 2013;4:25-31. [PMID: 28839698 DOI: 10.1136/flgastro-2012-100159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
623 Virta LJ, Kolho KL. Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009. ISRN Gastroenterol 2012;2012:462642. [PMID: 22957263 DOI: 10.5402/2012/462642] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
624 Fang K, Zhang S, Glawe J, Grisham MB, Kevil CG. Temporal genome expression profile analysis during t-cell-mediated colitis: identification of novel targets and pathways. Inflamm Bowel Dis 2012;18:1411-23. [PMID: 22179924 DOI: 10.1002/ibd.22842] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
625 Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, Dubinsky M, Kierkus J, Rosh J, Wang Y, Huang B, Bittle B, Marshall M, Lazar A. Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterology 2012;143:365-74.e2. [PMID: 22562021 DOI: 10.1053/j.gastro.2012.04.046] [Cited by in Crossref: 179] [Cited by in F6Publishing: 189] [Article Influence: 16.3] [Reference Citation Analysis]
626 Sherman PM, Brown S, Rose K, Murphy T, Makarchuk MJ, Paterson W, Belanger P. Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada. J Pediatr Gastroenterol Nutr 2012;55:125-30. [PMID: 22644466 DOI: 10.1097/MPG.0b013e3182604f3c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
627 Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 2012;46:581-9. [PMID: 22772738 DOI: 10.1097/MCG.0b013e318247c32f] [Cited by in Crossref: 132] [Cited by in F6Publishing: 123] [Article Influence: 12.0] [Reference Citation Analysis]
628 Ruemmele FM, Colombel JF. Commentaries on "Workshop report: developing a pediatric inflammatory bowel diseases network and data platform in Canada": networking in pediatric inflammatory bowel disease: the French GETAID Pédiatrique experience. J Pediatr Gastroenterol Nutr 2012;55:123. [PMID: 22644469 DOI: 10.1097/MPG.0b013e3182604f83] [Reference Citation Analysis]
629 Uchida K, Yoshiyama S, Inoue M, Koike Y, Yasuda H, Fujikawa H, Okita Y, Araki T, Tanaka K, Kusunoki M. Double balloon enteroscopy for pediatric inflammatory bowel disease. Pediatr Int. 2012;54:806-809. [PMID: 22564182 DOI: 10.1111/j.1442-200x.2012.03661.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
630 Sherlock ME, Griffiths AM. Medical therapy for pediatric inflammatory bowel disease. Curr Gastroenterol Rep. 2012;14:166-173. [PMID: 22350842 DOI: 10.1007/s11894-012-0249-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
631 Sidoroff M, Kolho KL. Glucocorticoids in pediatric inflammatory bowel disease. Scand J Gastroenterol 2012;47:745-50. [PMID: 22507033 DOI: 10.3109/00365521.2012.679681] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
632 Nagy-Szakal D, Ross MC, Dowd SE, Mir SA, Schaible TD, Petrosino JF, Kellermayer R. Maternal micronutrients can modify colonic mucosal microbiota maturation in murine offspring. Gut Microbes 2012;3:426-33. [PMID: 22713270 DOI: 10.4161/gmic.20697] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
633 Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, Gillett PM, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2012;107:941-9. [PMID: 22370604 DOI: 10.1038/ajg.2012.33] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 7.0] [Reference Citation Analysis]
634 Henderson P, Hansen R, Cameron FL, Gerasimidis K, Rogers P, Bisset WM, Reynish EL, Drummond HE, Anderson NH, Van Limbergen J, Russell RK, Satsangi J, Wilson DC. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012;18:999-1005. [PMID: 21688352 DOI: 10.1002/ibd.21797] [Cited by in Crossref: 144] [Cited by in F6Publishing: 178] [Article Influence: 13.1] [Reference Citation Analysis]
635 de Bie CI, Escher JC, de Ridder L. Antitumor necrosis factor treatment for pediatric inflammatory bowel disease. Inflamm Bowel Dis 2012;18:985-1002. [PMID: 21936033 DOI: 10.1002/ibd.21871] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
636 Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, Minelli F, Di Nardo G, Nuti F, Pierdomenico M, Cucchiara S, Stronati L. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:913-24. [PMID: 21994005 DOI: 10.1002/ibd.21899] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
637 Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study. Am J Epidemiol 2012;175:775-84. [PMID: 22366379 DOI: 10.1093/aje/kwr400] [Cited by in Crossref: 118] [Cited by in F6Publishing: 127] [Article Influence: 10.7] [Reference Citation Analysis]
638 Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, Desmet VJ, Fischer A, Roskams T, Wouters CH. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2–related disorders Blau syndrome and Crohn disease. Journal of Allergy and Clinical Immunology 2012;129:1076-84. [DOI: 10.1016/j.jaci.2012.02.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
639 Pirinen T, Kolho KL, Simola P, Ashorn M, Aronen ET. Parent-adolescent agreement on psychosocial symptoms and somatic complaints among adolescents with inflammatory bowel disease. Acta Paediatr 2012;101:433-7. [PMID: 22122226 DOI: 10.1111/j.1651-2227.2011.02541.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
640 . Current World Literature. Current Opinion in Rheumatology 2012;24:237-244. [DOI: 10.1097/bor.0b013e3283513e33] [Reference Citation Analysis]
641 Wiskin AE, Wootton SA, Cornelius VR, Afzal NA, Elia M, Beattie RM. No relation between disease activity measured by multiple methods and REE in childhood Crohn disease. J Pediatr Gastroenterol Nutr 2012;54:271-6. [PMID: 21921807 DOI: 10.1097/MPG.0b013e318236b19a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
642 Henderson P, Wilson DC, Satsangi J. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:391-2; discussion 392-3. [PMID: 22221081 DOI: 10.1111/j.1365-2036.2011.04921.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
643 Houston Y, O Lindsay J, Jenkins H, Mccartney S, Ahmad T, Arnott I, Croft N, Russell R, Sebastian S. Perspectives of transition care in inflammatory bowel disease: a survey. Gastrointestinal Nursing 2012;10:30-5. [DOI: 10.12968/gasn.2012.10.1.30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
644 Gathungu GN, Cho JH. The Genetics of Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_1] [Reference Citation Analysis]
645 Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.e42; quiz e30. [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001] [Cited by in Crossref: 3076] [Cited by in F6Publishing: 3287] [Article Influence: 279.6] [Reference Citation Analysis]
646 Adler J, Coran AG, Teitelbaum DH. Ulcerative Colitis. Pediatric Surgery 2012. [DOI: 10.1016/b978-0-323-07255-7.00096-9] [Reference Citation Analysis]
647 Dietert RR. Inflammatory Bowel Disease and Celiac Disease: Environmental Risks Factors and Consequences. Molecular and Integrative Toxicology 2012. [DOI: 10.1007/978-1-61779-812-2_12] [Reference Citation Analysis]
648 Kolho K, Klemola P, Simonen-tikka M, Ollonen M, Roivainen M. Enteric viral pathogens in children with inflammatory bowel disease. J Med Virol 2012;84:345-7. [DOI: 10.1002/jmv.23193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
649 Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, Jakobsen M, Kramer I, Czernia-Mazurkiewicz J, Wewer V. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflamm Bowel Dis 2011;17:2541-50. [PMID: 21381152 DOI: 10.1002/ibd.21654] [Cited by in Crossref: 92] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
650 Gouldthorpe O, Catto-Smith AG, Alex G. Biologics in paediatric Crohn's disease. Gastroenterol Res Pract 2011;2011:287574. [PMID: 22144993 DOI: 10.1155/2011/287574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
651 Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;53:480-8. [PMID: 21822149 DOI: 10.1097/MPG.0b013e31822f2c32] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
652 Boneberger A, Weiss EH, Calvo M, Torres L, Wagner J, Kabesch M, Radon K. Environmental factors in infancy and ulcerative colitis in the Central South of Chile: a case-control study. J Crohns Colitis 2011;5:392-6. [PMID: 21939911 DOI: 10.1016/j.crohns.2011.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
653 Hübner MP, Larson D, Torrero MN, Mueller E, Shi Y, Killoran KE, Mitre E. Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol 2011;141:205-17. [PMID: 21920822 DOI: 10.1016/j.clim.2011.08.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
654 Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One. 2011;6:e21490. [PMID: 21738679 DOI: 10.1371/journal.pone.0021490] [Cited by in Crossref: 101] [Cited by in F6Publishing: 115] [Article Influence: 8.4] [Reference Citation Analysis]
655 Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536-41. [PMID: 21407117 DOI: 10.1097/MPG.0b013e3181f87a95] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
656 Reikvam DH, Perminow G, Lyckander LG, Gran JM, Brandtzaeg P, Vatn M, Carlsen HS. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients. Scand J Gastroenterol 2011;46:550-60. [PMID: 21281255 DOI: 10.3109/00365521.2011.551887] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
657 Moeeni V, Day AS. Impact of Inflammatory Bowel Disease upon Growth in Children and Adolescents. ISRN Pediatr. 2011;2011:365712. [PMID: 22389775 DOI: 10.5402/2011/365712] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
658 Russell RK, Wilson ML, Loganathan S, Bourke B, Kiparissi F, Mahdi G, Torrente F, Rodrigues A, Davies I, Thomas A, Akobeng AK, Fagbemi A, Hyer W, Spray C, Vaish S, Rogers P, McGrogan P, Heuschkel RB, Ayub N, Fell JM, Afzal NA, Green M, Murphy MS, Rao P, Shah N, Ho GT, Naik S, Wilson DC. A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:946-53. [PMID: 21342211 DOI: 10.1111/j.1365-2036.2011.04603.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
659 Guilfoyle SM, Denson LA, Baldassano RN, Hommel KA. Paediatric parenting stress in inflammatory bowel disease: application of the Pediatric Inventory for Parents. Child Care Health Dev 2012;38:273-9. [PMID: 21299591 DOI: 10.1111/j.1365-2214.2010.01200.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
660 Hugot J, Martinez-vinson C, Viala J, Cézard J. Particularités des MICI chez l’enfant. Post’U FMC-HGE 2011. [DOI: 10.1007/978-2-8178-0237-4_11] [Reference Citation Analysis]